Aquí puede escribir una palabra clave, la DCI o los números CAS.
You can find your search history by clicking on the button on the left side of the search bar.
You can use the Advanced search by clicking on the Advanced search button, or you can use the following shortcuts:
Notes.
1.- (A) Goods (other than radioactive ores) answering to a description in heading 28.44 or 28.45 are to be classified in those headings and in no other heading of the Nomenclature.
(B) Subject to paragraph (A) above, goods answering to a description in heading 28.43, 28.46 or 28.52 are to be classified in those headings and in no other heading of this Section.
2.- Subject to Note 1 above, goods classifiable in heading 30.04, 30.05, 30.06, 32.12, 33.03, 33.04, 33.05, 33.06, 33.07, 35.06, 37.07 or 38.08 by reason of being put up in measured doses or for retail sale are to be classified in those headings and in no other heading of the Nomenclature.
3.- Goods put up in sets consisting of two or more separate constituents, some or all of which fall in this Section and are intended to be mixed together to obtain a product of Section VI or VII, are to be classified in the heading appropriate to that product, provided that the constituents are :
(a) having regard to the manner in which they are put up, clearly identifiable as being intended to be used together without first being repacked;
(b) presented together; and
(c) identifiable, whether by their nature or by the relative proportions in which they are present, as being complementary one to another.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
Notes.
1.- Except where the context otherwise requires, the headings of this Chapter apply only to :
(a) Separate chemically defined organic compounds, whether or not containing impurities;
(b) Mixtures of two or more isomers of the same organic compound (whether or not containing impurities), except mixtures of acyclic hydrocarbon isomers (other than stereoisomers), whether or not saturated (Chapter 27);
(c) The products of headings 29.36 to 29.39 or the sugar ethers, sugar acetals and sugar esters, and their salts, of heading 29.40, or the products of heading 29.41, whether or not chemically defined;
(d) The products mentioned in (a), (b) or (c) above dissolved in water;
(e) The products mentioned in (a), (b) or (c) above dissolved in other solvents provided that the solution constitutes a normal and necessary method of putting up these products adopted solely for reasons of safety or for transport and that the solvent does not render the product particularly suitable for specific use rather than for general use;
(f) The products mentioned in (a), (b), (c), (d) or (e) above with an added stabiliser (including an anti-caking agent) necessary for their preservation or transport;
(g) The products mentioned in (a), (b), (c), (d), (e) or (f) above with an added anti-dusting agent or a colouring or odoriferous substance added to facilitate their identification or for safety reasons, provided that the additions do not render the product particularly suitable for specific use rather than for general use;
(h) The following products, diluted to standard strengths, for the production of azo dyes : diazonium salts, couplers used for these salts and diazotisable amines and their salts.
2.- This Chapter does not cover :
(a) Goods of heading 15.04 or crude glycerol of heading 15.20;
(b) Ethyl alcohol (heading 22.07 or 22.08);
(c) Methane or propane (heading 27.11);
(d) The compounds of carbon mentioned in Note 2 to Chapter 28;
(e) Immunological products of heading 30.02.
(f) Urea (heading 31.02 or 31.05);
(g) Colouring matter of vegetable or animal origin (heading 32.03), synthetic organic colouring matter, synthetic organic products of a kind used as fluorescent brightening agents or as luminophores (heading 32.04) or dyes or other colouring matter put up in forms or packings for retail sale (heading 32.12);
(h) Enzymes (heading 35.07);
(ij) Metaldehyde, hexamethylenetetramine or similar substances, put up in forms (for example, tablets, sticks or similar forms) for use as fuels, or liquid or liquefied-gas fuels in containers of a kind used for filling or refilling cigarette or similar lighters and of a capacity not exceeding 300 cm3 (heading 36.06);
(k) Products put up as charges for fire-extinguishers or put up in fire-extinguishing grenades, of heading 38.13; ink removers put up in packings for retail sale, of heading 38.24; or
(l) Optical elements, for example, of ethylenediamine tartrate (heading 90.01).
3.- Goods which could be included in two or more of the headings of this Chapter are to be classified in that one of those headings which occurs last in numerical order.
4.- In headings 29.04 to 29.06, 29.08 to 29.11 and 29.13 to 29.20, any reference to halogenated, sulphonated, nitrated or nitrosated derivatives includes a reference to compound derivatives, such as sulphohalogenated, nitrohalogenated, nitrosulphonated or nitrosulphohalogenated derivatives.
Nitro or nitroso groups are not to be taken as “nitrogen-functions” for the purpose of heading 29.29.
For the purposes of headings 29.11, 29.12, 29.14, 29.18 and 29.22, “oxygen-function” is to be restricted to the functions (the characteristic organic oxygen-containing groups) referred to in headings 29.05 to 29.20.
5.- (A) The esters of acid-function organic compounds of sub-Chapters I to VII with organic compounds of these sub-Chapters are to be classified with that compound which is classified in the heading which occurs last in numerical order in these sub-Chapters.
(B) Esters of ethyl alcohol with acid-function organic compounds of sub-Chapters I to VII are to be classified in the same heading as the corresponding acid-function compounds.
(C) Subject to Note 1 to Section VI and Note 2 to Chapter 28 :
(1) Inorganic salts of organic compounds such as acid-, phenol- or enol-function compounds or organic bases, of sub-Chapters I to X or heading 29.42, are to be classified in the heading appropriate to the organic compound;
(2) Salts formed between organic compounds of sub-Chapters I to X or heading 29.42 are to be classified in the heading appropriate to the base or to the acid (including phenol- or enol-function compounds) from which they are formed, whichever occurs last in numerical order in the Chapter; and
(3) Co-ordination compounds, other than products classifiable in sub-Chapter XI or heading 29.41, are to be classified in the heading which occurs last in numerical order in Chapter 29, among those appropriate to the fragments formed by “cleaving” of all metal bonds, other than metal-carbon bonds.
(D) Metal alcoholates are to be classified in the same heading as the corresponding alcohols except in the case of ethanol (heading 29.05).
(E) Halides of carboxylic acids are to be classified in the same heading as the corresponding acids.
6.- The compounds of headings 29.30 and 29.31 are organic compounds the molecules of which contain, in addition to atoms of hydrogen, oxygen or nitrogen, atoms of other non-metals or of metals (such as sulphur, arsenic or lead) directly linked to carbon atoms.
Heading 29.30 (organo-sulphur compounds) and heading 29.31 (other organo-inorganic compounds) do not include sulphonated or halogenated derivatives (including compound derivatives) which, apart from hydrogen, oxygen and nitrogen, only have directly linked to carbon the atoms of sulphur or of a halogen which give them their nature of sulphonated or halogenated derivatives (or compound derivatives).
7.- Headings 29.32, 29.33 and 29.34 do not include epoxides with a three-membered ring, ketone peroxides, cyclic polymers of aldehydes or of thioaldehydes, anhydrides of polybasic carboxylic acids, cyclic esters of polyhydric alcohols or phenols with polybasic acids, or imides of polybasic acids.
These provisions apply only when the ring-position hetero-atoms are those resulting solely from the cyclising function or functions here listed.
8.- For the purposes of heading 29.37 :
(a) the term “hormones” includes hormone-releasing or hormone-stimulating factors, hormone inhibitors and hormone antagonists (anti-hormones);
(b) the expression “used primarily as hormones” applies not only to hormone derivatives and structural analogues used primarily for their hormonal effect, but also to those derivatives and structural analogues used primarily as intermediates in the synthesis of products of this heading.
°
° °
Subheading Notes.
1.- Within any one heading of this Chapter, derivatives of a chemical compound (or group of chemical compounds) are to be classified in the same subheading as that compound (or group of compounds) provided that they are not more specifically covered by any other subheading and that there is no residual subheading named “Other” in the series of subheadings concerned.
2.- Note 3 to Chapter 29 does not apply to the subheadings of this Chapter.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
You must log in to see this content and use many functionalities
No account ? Learn more about our subscription offers.
LIST
OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ARRANGED IN ALPHABETICAL ORDER BY TYPE OF DRUG
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol
|
Name |
HS subheading |
CAS No. |
Convention Schedule No |
|
Acetorphine (INN) |
2939.19 |
25333-77-1 |
4 |
|
Acetorphine hydrochloride |
2939.19 |
25333-78-2 |
4 |
|
Acetyldihydrocodeine |
2939.19 |
3861-72-1 |
2 |
|
Acetyldihydrocodeine hydrochloride |
2939.19 |
|
2 |
|
Acetylmethadol (INN) |
2922.19 |
509-74-0 |
1 |
|
Acetyl-a-methylfentanyl |
2933.39 |
|
4 |
|
Acetylmorphine |
2939.19 |
|
1 |
|
3-Acetylmorphine |
2939.19 |
|
1 |
|
6-Acetylmorphine |
2939.19 |
2784-73-8 |
1 |
|
Alfentanil (INN) |
2933.33 |
71195-58-9 |
1 |
|
Alfentanil hydrochloride |
2933.33 |
69049-06-5 |
1 |
|
Allylprodine (INN) |
2933.39 |
25384-17-2 |
1 |
|
Allylprodine hydrochloride |
2933.39 |
|
1 |
|
Alphacetylmethadol (INN) |
2922.19 |
17199-58-5 |
1 |
|
L-Alphacetylmethadol |
2922.19 |
|
|
|
Alphacetylmethadol hydrochloride |
2922.19 |
|
1 |
|
Alphameprodine (INN) |
2933.39 |
468-51-9 |
1 |
|
Alphamethadol (INN) |
2922.19 |
17199-54-1 |
1 |
|
Alphaprodine (INN) |
2933.39 |
77-20-3 |
1 |
|
Alphaprodine hydrochloride |
2933.39 |
561-78-4 |
1 |
|
Anileridine (INN) |
2933.33 |
144-14-9 |
1 |
|
Anileridine dihydrochloride |
2933.33 |
126-12-5 |
1 |
|
Anileridine phosphate |
2933.39 |
4268-37-5 |
1 |
|
Benzethidine (INN) |
2933.39 |
3691-78-9 |
1 |
|
Benzethidine hydrobromide |
2933.39 |
|
1 |
|
Benzethidine hydrochloride |
2933.39 |
|
1 |
|
Benzoylmorphine |
2939.19 |
|
1 |
|
Benzylmorphine |
2939.19 |
14297-87-1 |
1 |
|
Benzylmorphine hydrochloride |
2939.19 |
630-86-4 |
1 |
|
Benzylmorphine mesilate |
2939.19 |
|
1 |
|
Betacetylmethadol (INN) |
2922.19 |
17199-59-6 |
1 |
|
Betameprodine (INN) |
2933.39 |
468-50-8 |
1 |
|
Betamethadol (INN) |
2922.19 |
17199-55-2 |
1 |
|
Betaprodine (INN) |
2933.39 |
468-59-7 |
1 |
|
Betaprodine hydrochloride |
2933.39 |
|
1 |
|
Bezitramide (INN) |
2933.33 |
15301-48-1 |
1 |
|
Bezitramide hydrochloride |
2933.33 |
|
1 |
|
Cannabis |
1211.90 |
|
4 |
|
Cannabis extracts and tinctures |
1302.19 |
|
|
|
Cannabis oil |
1302.19 |
|
|
|
Cannabis resin |
1301.90 |
|
|
|
Clonitazene (INN) |
2933.99 |
3861-76-5 |
1 |
|
Clonitazene hydrochloride |
2933.99 |
|
1 |
|
Clonitazene mesilate |
2933.99 |
|
1 |
|
Coca leaf |
1211.30 |
|
|
|
Cocaine |
2939.71 |
50-36-2 |
1 |
|
d-Cocaine |
2939.71 |
478-73-9 |
|
|
Cocaine benzoate |
2939.71 |
|
1 |
|
Cocaine borate |
2939.71 |
|
1 |
|
Cocaine citrate |
2939.71 |
|
1 |
|
Cocaine formate |
2939.71 |
|
1 |
|
Cocaine hydriodide |
2939.71 |
|
1 |
|
Cocaine hydrobromide |
2939.71 |
|
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Cocaine hydrochloride |
2939.71 |
53-21-4 |
1 |
|
Cocaine lactate |
2939.71 |
1 |
|
|
Cocaine nitrate |
2939.71 |
5913-62-2 |
1 |
|
Cocaine salicylate |
2939.71 |
5913-64-4 |
1 |
|
Cocaine sulfate |
2939.71 |
1 |
|
|
Cocaine tartrate |
2939.71 |
1 |
|
|
Codeine |
2939.11 |
76-57-3 |
2 |
|
Codeine acetate |
2939.11 |
2 |
|
|
Codeine allobarbiturate |
2939.11 |
2 |
|
|
Codeine barbiturate |
2939.11 |
2 |
|
|
Codeine camphosulfonate |
2939.11 |
2 |
|
|
Codeine citrate |
2939.11 |
5913-73-5 |
2 |
|
Codeine cyclobarbiturate |
2939.11 |
2 |
|
|
Codeine cyclopentobarbiturate |
2939.11 |
2 |
|
|
Codeine 6-glucuronide |
2939.19 |
2 |
|
|
Codeine hydrobromide |
2939.11 |
125-25-7 |
2 |
|
Codeine hydrochloride |
2939.11 |
1422-07-7 |
2 |
|
Codeine hydroiodide |
2939.11 |
125-26-8 |
2 |
|
Codeine methylbromide |
2939.19 |
125-27-9 |
2 |
|
Codeine phenobarbiturate |
2939.11 |
2 |
|
|
Codeine phosphate |
2939.11 |
52-28-8 |
2 |
|
Codeine resinate |
3003.49 |
2 |
|
|
Codeine salicylate |
2939.11 |
2 |
|
|
Codeine sulfate |
2939.11 |
1420-53-7 |
2 |
|
Codeine-N-oxide |
2939.19 |
3688-65-1 |
|
|
Codeine-N-oxide hydrochloride |
2939.19 |
||
|
Codoxime (INN) |
2939.19 |
7125-76-0 |
1 |
|
Concentrate of poppy straw |
1302.11 |
1 |
|
|
2939.11 |
|
||
|
Desomorphine (INN) |
2939.19 |
427-00-9 |
4 |
|
Desomorphine hydrobromide |
2939.19 |
4 |
|
|
Desomorphine hydrochloride |
2939.19 |
4 |
|
|
Desomorphine sulfate |
2939.19 |
4 |
|
|
Dextromoramide (INN) |
2934.91 |
357-56-2 |
1 |
|
Dextromoramide dihydrochloride |
2934.91 |
1 |
|
|
Dextromoramide hydrochloride |
2934.91 |
1 |
|
|
Dextromoramide hydrogen tartrate (bitartrate) |
2934.99 |
2922-44-3 |
1 |
|
Dextropropoxyphene (INN) |
2922.14 |
469-62-5 |
2 |
|
Dextropropoxyphene hydrochloride |
2922.14 |
1639-60-7 |
2 |
|
Napsilate |
2922.19 |
17140-78-2 |
2 |
|
Dextropropoxyphene resinate |
3003.90 |
2 |
|
|
Diampromide (INN) |
2924.29 |
552-25-0 |
1 |
|
Diampromide sulfate |
2924.29 |
1 |
|
|
Diethylthiambutene (INN) |
2934.99 |
86-14-6 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Diethylthiambutene hydrochloride |
2934.99 |
132-19-4 |
1 |
|
Difenoxin (INN) |
2933.33 |
28782-42-5 |
1 |
|
Difenoxin hydrochloride |
2933.33 |
35607-36-4 |
1 |
|
Dihydrocodeine (INN) |
2939.11 |
125-28-0 |
2 |
|
Dihydrocodeine hydrochloride |
2939.11 |
2 |
|
|
Dihydrocodeine hydrogen tartrate (bitartrate) |
2939.11 |
5965-13-9 |
2 |
|
Dihydrocodeine phosphate |
2939.11 |
24204-13-5 |
2 |
|
Dihydrocodeine resinate |
3003.49 |
2 |
|
|
Dihydrocodeine thiocyanate |
2939.11 |
2 |
|
|
Dihydroisomorphin |
2939.19 |
||
|
Dihydroisomorphin 6-glucuronide |
2939.19 |
||
|
Dihydromorphine |
2939.19 |
509-60-4 |
2 |
|
Dihydromorphine hydriodide |
2939.19 |
2 |
|
|
Dihydromorphine hydrochloride |
2939.19 |
1421-28-9 |
2 |
|
Dihydromorphine picrate |
2939.19 |
2 |
|
|
Dimenoxadol (INN) |
2922.19 |
509-78-4 |
1 |
|
Dimenoxadol hydrochloride |
2922.19 |
242-75-1 |
1 |
|
Dimepheptanol (INN) |
2922.19 |
545-90-4 |
1 |
|
Dimepheptanol hydrochloride |
2922.19 |
1 |
|
|
Dimethylthiambutene (INN) |
2934.99 |
524-84-5 |
1 |
|
Dimethylthiambutene hydrochloride |
2934.99 |
1 |
|
|
Dioxaphetyl butyrate (INN) |
2934.99 |
467-86-7 |
1 |
|
Dioxaphetyl butyrate hydrochloride |
2934.99 |
1 |
|
|
Diphenoxylate (INN) |
2933.33 |
915-30-0 |
1 |
|
Diphenoxylate hydrochloride |
2933.33 |
3810-80-8 |
1 |
|
Dipipanone (INN) |
2933.33 |
467-83-4 |
1 |
|
Dipipanone hydrobromide |
2933.33 |
1 |
|
|
Dipipanone hydrochloride |
2933.33 |
75783-06-1 |
1 |
|
Drotebanol (INN) |
2933.49 |
3176-03-2 |
1 |
|
Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine |
2939.71 |
481-37-8 |
1 |
|
Ecgonine benzoylethyl ester |
2939.71 |
1 |
|
|
Ecgonine benzoylpropyl ester |
2939.71 |
1 |
|
|
Ecgonine cinnamoylmethyl ester |
2939.71 |
1 |
|
|
Ecgonine 2,6-dimethyl-benzoylmethyl ester |
2939.71 |
1 |
|
|
Ecgonine hydrochloride |
2939.71 |
1 |
|
|
Ecgonine methyl ester |
2939.71 |
1 |
|
|
Ecgonine methyl ester hydrochloride |
2939.71 |
1 |
|
|
Ecgonine phenylacetyl-methyl ester |
2939.71 |
1 |
|
|
Ethylmethylthiambutene (INN) |
2934.99 |
441-61-2 |
1 |
|
Ethylmethylthiambutene hydrochloride |
2934.99 |
1 |
|
|
Ethylmorphine |
2939.11 |
76-58-4 |
2 |
|
Ethylmorphine camphosulfonate |
2939.11 |
2 |
|
|
Ethylmorphine hydrobromide |
2939.11 |
2 |
|
|
Ethylmorphine hydrochloride |
2939.11 |
125-30-4 |
2 |
|
Ethylmorphine methyliodide |
2939.19 |
2 |
|
|
Ethylmorphine phenobarbiturate |
2939.11 |
2 |
|
|
Etonitazene (INN) |
2933.99 |
911-65-9 |
1 |
|
Etonitazene hydrochloride |
2933.99 |
1 |
|
|
Etorphine (INN) |
2939.11 |
14521-96-1 |
4 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Etorphine hydrochloride |
2939.11 |
13764-49-3 |
4 |
|
Etorphine 3-methyl ether |
2939.19 |
4 |
|
|
Etoxeridine (INN) |
2933.39 |
469-82-9 |
1 |
|
Etoxeridine hydrochloride |
2933.39 |
1 |
|
|
Fentanyl (INN) |
2933.33 |
437-38-7 |
1 |
|
Fentanyl citrate |
2933.33 |
990-73-8 |
1 |
|
p-Fluorofentanyl |
2933.39 |
4 |
|
|
p-Fluorofentanyl hydrochloride |
2933.39 |
4 |
|
|
Furethidine (INN) |
2934.99 |
2385-81-1 |
1 |
|
Furethidine hydrobromide |
2934.99 |
1 |
|
|
Furethidine methyliodide |
2934.99 |
1 |
|
|
Furethidine picrate |
2934.99 |
1 |
|
|
Heroin |
2939.11 |
561-27-3 |
4 |
|
Heroin hydrochloride |
2939.11 |
1502-95-0 |
4 |
|
Heroin methyliodide |
2939.19 |
4 |
|
|
Hydrocodone (INN) |
2939.11 |
125-29-1 |
1 |
|
Hydrocodone citrate |
2939.11 |
1 |
|
|
Hydrocodone hydriodide |
2939.11 |
1 |
|
|
Hydrocodone hydrochloride |
2939.11 |
25968-91-6 |
1 |
|
Hydrocodone hydrogen tartrate (bitartrate) |
2939.11 |
143-71-5 |
1 |
|
Hydrocodone methyliodide |
2939.19 |
1 |
|
|
Hydrocodone phosphate |
2939.11 |
34366-67-1 |
1 |
|
Hydrocodone resinate |
3003.49 |
1 |
|
|
Hydrocodone terephthalate |
2939.11 |
1 |
|
|
Hydromorphinol (INN) |
2939.19 |
2183-56-4 |
1 |
|
Hydromorphinol hydrochloride |
2939.19 |
1 |
|
|
Hydromorphinol hydrogen tartrate (bitartrate) |
2939.19 |
1 |
|
|
Hydromorphone (INN) |
2939.11 |
466-99-9 |
1 |
|
Hydromorphone hydrochloride |
2939.11 |
71-68-1 |
1 |
|
Hydromorphone sulfate |
2939.11 |
1 |
|
|
Hydromorphone terephthalate |
2939.11 |
1 |
|
|
ß-Hydroxyfentanyl |
2933.39 |
4 |
|
|
ß-Hydroxyfentanyl hydrochloride |
2933.39 |
4 |
|
|
(+)-cis-ß-Hydroxy-3-m-methylfentanyl |
2933.39 |
||
|
ß-Hydroxy-3-methylfentanyl |
2933.39 |
4 |
|
|
ß-Hydroxy-3-methylfentanyl hydrochloride |
2933.39 |
4 |
|
|
Hydroxypethidine (INN) |
2933.39 |
468-56-4 |
1 |
|
Hydroxypethidine hydrochloride |
2933.39 |
1 |
|
|
Isomethadone (INN) |
2922.39 |
466-40-0 |
1 |
|
d-Isomethadone |
2922.39 |
||
|
l-Isomethadone |
2922.39 |
||
|
Isomethadone hydrobromide |
2922.39 |
1 |
|
|
Isomethadone hydrochloride |
2922.39 |
1 |
|
|
Ketobemidone (INN) |
2933.33 |
469-79-4 |
4 |
|
Ketobemidone hydrochloride |
2933.33 |
5965-49-1 |
4 |
|
Levacetylmethadol (INN) |
2922.19 |
34433-66-4 |
1 |
|
Levomethorphan (INN)(*) |
2933.49 |
125-70-2 |
1 |
|
Levomethorphan hydrobromide |
2933.49 |
1 |
|
|
Levomethorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Levomoramide (INN) |
2934.99 |
5666-11-5 |
1 |
|
Levomoramide dihydrochloride |
2934.99 |
1 |
|
|
Levophenacylmorphan (INN) |
2933.49 |
10061-32-2 |
1 |
|
Levophenacylmorphan hydrochloride |
2933.49 |
1 |
|
|
Levophenacylmorphan methylsulfonate |
2933.49 |
1 |
|
|
Levopropoxyphene (INN) |
2922.19 |
2338-37-6 |
|
|
Levorphanol (INN)(**) |
2933.41 |
77-07-6 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Levorphanol hydrogen tartrate (bitartrate) |
2933.41 |
125-72-4 |
1 |
|
Levorphanol hydrochloride |
2933.41 |
1 |
|
|
Metazocine (INN) |
2933.39 |
3734-52-9 |
1 |
|
Metazocine hydrobromide |
2933.39 |
1 |
|
|
Metazocine hydrochloride |
2933.39 |
1 |
|
|
l-Methadol |
2922.19 |
||
|
Methadone (INN) |
2922.31 |
76-99-3 |
1 |
|
d-Methadone |
2922.31 |
||
|
l-Methadone |
2922.31 |
1 |
|
|
Methadone hydrobromide |
2922.31 |
1 |
|
|
Methadone hydrochloride |
2922.31 |
1095-90-5 |
1 |
|
Methadone hydrogen tartrate (bitartrate) |
2922.31 |
1 |
|
|
d-Methadone hydrochloride |
2922.31 |
||
|
l-Methadone hydrochloride |
2922.31 |
||
|
l-Methadone hydrogen tartrate (bitartrate) |
2922.31 |
1 |
|
|
Methadone (INN) intermediate4-cyano-2-dimethylamino-4,4-diphenylbutane or 2-dimethylamino-4,4-diphenyl-4-cyanobutane |
2926.30 |
1 |
|
|
Methyldesorphine (INN) |
2939.19 |
16008-36-9 |
1 |
|
Methyldesorphine hydrochloride |
2939.19 |
1 |
|
|
Methyldihydromorphine (INN) |
2939.19 |
509-56-8 |
1 |
|
3-Methylfentanyl |
2933.39 |
4 |
|
|
3-Methylfentanyl hydrochloride |
2933.39 |
|
4 |
|
α-Methylfentanyl |
2933.39 |
4 |
|
|
α-Methylfentanyl hydrochloride |
2933.39 |
4 |
|
|
α-Methylthiofentanyl |
2934.99 |
1 |
|
|
α-Methylthiofentanyl hydrochloride |
2934.99 |
1 |
|
|
3-Methylthiofentanyl |
2934.99 |
4 |
|
|
3-Methylthiofentanyl hydrochloride |
2934.99 |
4 |
|
|
(+)-cis-3-Methylthiofentanyl |
2934.99 |
4 |
|
|
(+)-cis-3-Methylthioentanyl-hydrochloride |
2934.99 |
||
|
Metopon (INN) |
2939.19 |
143-52-2 |
1 |
|
Metopon hydrochloride |
2939.19 |
1 |
|
|
Moramide intermediate |
2934.99 |
1 |
|
|
Morpheridine (INN) |
2934.99 |
469-81-8 |
1 |
|
Morpheridine dihydrochloride |
2934.99 |
1 |
|
|
Morpheridine picrate |
2934.99 |
1 |
|
|
Morphine |
2939.11 |
57-27-2 |
1 |
|
Morphine acetate |
2939.11 |
596-15-6 |
1 |
|
Morphine citrate |
2939.11 |
1 |
|
|
Morphine 3,6-diglucuronide |
2939.19 |
1 |
|
|
Morphine dimethyl ether |
2939.19 |
||
|
Morphine gluconate |
2939.19 |
1 |
|
|
Morphine 3-glucuronide |
2939.19 |
1 |
|
|
Morphine 3-glucuronide |
2939.19 |
1 |
|
|
Morphine 6-glucuronide |
2939.19 |
1 |
|
|
Morphine 3-β-D-glucuronide |
2939.19 |
1 |
|
|
Morphine 6-β-D-glucuronide |
2939.19 |
1 |
|
|
Morphine hydriodide |
2939.11 |
1 |
|
|
Morphine hydrobromide |
2939.11 |
630-81-9 |
1 |
|
Morphine hydrochloride |
2939.11 |
52-26-6 |
1 |
|
Morphine hypophosphite |
2939.11 |
1 |
|
|
Morphine isobutyrate |
2939.11 |
1 |
|
|
Morphine lactate |
2939.11 |
1 |
|
|
Morphine meconate |
2939.11 |
1 |
|
|
Morphine methobromide |
2939.19 |
1 |
|
|
Morphine methylbromide |
2939.19 |
1 |
|
|
Morphine methylchoride |
2939.19 |
1 |
|
|
Morphine methyliodide |
2939.19 |
1 |
|
|
Morphine methylsulfonate |
2939.11 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Morphine mucate |
2939.11 |
1 |
|
|
Morphine nitrate |
2939.11 |
596-16-7 |
1 |
|
Morphine phenylpropionate |
2939.11 |
1 |
|
|
Morphine phosphate |
2939.11 |
1 |
|
|
Morphine phthalate |
2939.11 |
1 |
|
|
Morphine stearate |
2939.11 |
1 |
|
|
Morphine sulfate |
2939.11 |
64-31-3 |
1 |
|
Morphine tartrate |
2939.11 |
302-31-8 |
1 |
|
Morphine valerate |
2939.11 |
1 |
|
|
Morphine-N-oxide |
2939.19 |
639-46-3 |
1 |
|
Morphine-N-oxide quinate |
2939.19 |
1 |
|
|
MPPP |
2933.39 |
4 |
|
|
MPPP hydrochloride |
2933.39 |
4 |
|
|
MT-45 |
2933.59 |
1 |
|
|
Myrophine (INN) |
2939.19 |
467-18-5 |
1 |
|
Myrophine hydrochloride |
2939.19 |
1 |
|
|
Nicocodine (INN) |
2939.19 |
3688-66-2 |
2 |
|
Nicocodine hydrochloride |
2939.19 |
2 |
|
|
Nicodicodine (INN) |
2939.19 |
808-24-2 |
2 |
|
Nicomorphine (INN) |
2939.11 |
639-48-5 |
1 |
|
Nicomorphine hydrochloride |
2939.11 |
1 |
|
|
Noracymethadol (INN) |
2922.19 |
1477-39-0 |
1 |
|
Noracymethadol gluconate |
2922.19 |
1 |
|
|
Noracymethadol hydrochloride |
2922.19 |
1 |
|
|
Norcodeine (INN) |
2939.19 |
467-15-2 |
2 |
|
Norcodeine acetate |
2939.19 |
2 |
|
|
Norcodeine hydriodide |
2939.19 |
2 |
|
|
Norcodeine hydrochloride |
2939.19 |
14648-14-7 |
2 |
|
Norcodeine nitrate |
2939.19 |
2 |
|
|
Norcodeine platinichloride |
2843.90 |
2 |
|
|
Norcodeine sulfate |
2939.19 |
2 |
|
|
Norlevorphanol (INN) |
2933.49 |
1531-12-0 |
1 |
|
Norlevorphanol hydrobromide |
2933.49 |
1 |
|
|
Norlevorphanol hydrochloride |
2933.49 |
1 |
|
|
Normethadone (INN) |
2922.31 |
467-85-6 |
1 |
|
Normethadone 2,6-di-tert- butylnaphthalenedisulfonate |
2922.31 |
1 |
|
|
Normethadone hydrobromide |
2922.31 |
1 |
|
|
Normethadone hydrochloride |
2922.31 |
847-84-7 |
1 |
|
Normethadone methyliodide |
2922.39 |
1 |
|
|
Normethadone oxalate |
2922.31 |
1 |
|
|
Normethadone picrate |
2922.31 |
1 |
|
|
Normethadone (INN) intermediate |
2926.90 |
||
|
Normorphine (INN) |
2939.19 |
466-97-7 |
1 |
|
Normorphine hydrochloride |
2939.19 |
1 |
|
|
Norpipanone (INN) |
2933.39 |
561-48-8 |
1 |
|
Norpipanone hydrobromide |
2933.39 |
1 |
|
|
Norpipanone hydrochloride |
2933.39 |
1 |
|
|
Ocfentanil (INN) |
2933.39 |
1 |
|
|
Opium |
1302.11 |
1 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Opium, mixed alkaloids of |
1302.11(*) |
||
|
2939.11(**) |
|||
|
Opium, prepared |
1302.19 |
||
|
2939.11 |
|||
|
Oripavine |
2939.19 |
|
1 |
|
Oripavine hydrochloride |
2939.19 |
|
1 |
|
Oxycodone (INN) |
2939.11 |
76-42-6 |
1 |
|
Oxycodone camphosulfonate |
2939.11 |
1 |
|
|
Oxycodone hydrochloride |
2939.11 |
124-90-3 |
1 |
|
Oxycodone hydrogen tartrate (bitartrate) |
2939.11 |
1 |
|
|
Oxycodone pectinate |
2939.11 |
1 |
|
|
Oxycodone phenylpropionate |
2939.11 |
1 |
|
|
Oxycodone phosphate |
2939.11 |
1 |
|
|
Oxycodone terephthalate |
2939.11 |
1 |
|
|
Oxymorphone (INN) |
2939.11 |
76-41-5 |
1 |
|
Oxymorphone hydrochloride |
2939.11 |
357-07-3 |
1 |
|
Papaver bracteatum |
1211.90 |
||
|
PEPAP |
2933.39 |
4 |
|
|
PEPAP hydrochloride |
2933.39 |
4 |
|
|
Pethidine (INN) |
2933.33 |
57-42-1 |
1 |
|
Pethidine hydrochloride |
2933.33 |
50-13-5 |
1 |
|
Pethidine (INN) intermediate A |
2933.33 |
1 |
|
|
Pethidine (INN) intermediate B |
2933.39 |
1 |
|
|
Pethidine intermediate B hydrobromide |
2933.39 |
1 |
|
|
Pethidine intermediate B hydrochloride |
2933.39 |
1 |
|
|
Pethidine (INN) intermediate C |
2933.39 |
1 |
|
|
Phenadoxone (INN) |
2934.99 |
467-84-5 |
1 |
|
Phenadoxone hydrochloride |
2934.99 |
545-91-5 |
1 |
|
Phenampromide (INN) |
2933.39 |
129-83-9 |
1 |
|
Phenampromide hydrochloride |
2933.39 |
1 |
|
|
Phenazocine (INN) |
2933.39 |
127-35-5 |
1 |
|
Phenazocine hydrobromide |
2933.39 |
1 |
|
|
Phenazocine hydrochloride |
2933.39 |
7303-75-5 |
1 |
|
Phenazocine mesilate |
2933.39 |
1 |
|
|
Phenomorphan (INN) |
2933.49 |
468-07-5 |
1 |
|
Phenomorphan hydrobromide |
2933.49 |
1 |
|
|
Phenomorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Phenomorphan methylbromide |
2933.49 |
1 |
|
|
Phenoperidine (INN) |
2933.33 |
562-26-5 |
1 |
|
Phenoperidine hydrochloride |
2933.33 |
3627-49-4 |
1 |
|
Pholcodine (INN) |
2939.11 |
509-67-1 |
2 |
|
Pholcodine hydrogen tartrate (bitartrate) |
2939.11 |
2 |
|
|
Pholcodine citrate |
2939.11 |
2 |
|
|
Pholcodine guaiacolsulfonate |
2939.11 |
2 |
|
|
Pholcodine hydrochloride |
2939.11 |
2 |
|
|
Pholcodine phenylacetate |
2939.11 |
2 |
I. Narcotic drugs subject to control under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Pholcodine phosphate |
2939.11 |
2 |
|
|
Pholcodine sulfonate |
2939.11 |
2 |
|
|
Pholcodine tartrate |
2939.11 |
7369-11-1 |
2 |
|
Piminodine (INN) |
2933.39 |
13495-09-5 |
1 |
|
Piminodine dihydrochloride |
2933.39 |
1 |
|
|
Piminodine esilate |
2933.39 |
7081-52-9 |
1 |
|
Piritramide (INN) |
2933.33 |
302-41-0 |
1 |
|
Poppy straw |
1211.40 |
||
|
Proheptazine (INN) |
2933.99 |
77-14-5 |
1 |
|
Proheptazine citrate |
2933.99 |
1 |
|
|
Proheptazine hydrobromide |
2933.99 |
1 |
|
|
Proheptazine hydrochloride |
2933.99 |
1 |
|
|
Properidine (INN) |
2933.39 |
561-76-2 |
1 |
|
Properidine hydrochloride |
2933.39 |
1 |
|
|
Propiram (INN) |
2933.33 |
15686-91-6 |
2 |
|
Propiram fumarate |
2933.33 |
2 |
|
|
Racemethorphan (INN) |
2933.49 |
510-53-2 |
1 |
|
Racemethorphan hydrobromide |
2933.49 |
1 |
|
|
Racemethorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Racemoramide (INN) |
2934.99 |
545-59-5 |
1 |
|
Racemoramide dihydrochloride |
2934.99 |
1 |
|
|
Racemoramide hydrogen tartrate (bitartrate) |
2934.99 |
1 |
|
|
Racemoramide tartrate |
2934.99 |
1 |
|
|
Racemorphan (INN) |
2933.49 |
297-90-5 |
1 |
|
Racemorphan hydrobromide |
2933.49 |
1 |
|
|
Racemorphan hydrochloride |
2933.49 |
1 |
|
|
Racemorphan hydrogen tartrate (bitartrate) |
2933.49 |
1 |
|
|
Remifentanil (INN) |
2933.39 |
1 |
|
|
Remifentanil hydrochloride |
2933.39 |
1 |
|
|
Sufentanil (INN) |
2934.91 |
56030-54-7 |
1 |
|
Sufentanil citrate |
2934.91 |
1 |
|
|
Thebacon (INN) |
2939.11 |
466-90-0 |
1 |
|
Thebacon hydrochloride |
2939.11 |
20236-82-2 |
1 |
|
Thebaine hydrochloride |
2939.11 |
1 |
|
|
Thebaine hydrogen tartrate (bitartrate) |
2939.11 |
1 |
|
|
Thebaine oxalate |
2939.11 |
1 |
|
|
Thebaine salicylate |
2939.11 |
1 |
|
|
Tetrahydrofuranylfentanyl |
2934.99 |
1 |
|
|
Thiofentanyl |
2934.99 |
4 |
|
|
Thiofentanyl acetate |
2934.99 |
1 |
|
|
Thiofentanyl hydrochloride |
2934.99 |
4 |
|
|
Tilidine (INN) |
2922.44 |
20380-58-9 |
1 |
|
Tilidine hydrochloride |
2922.44 |
27107-79-5 |
1 |
|
Trimeperidine (INN) |
2933.33 |
64-39-1 |
1 |
|
Trimeperidine hydrochloride |
2933.33 |
125-80-4 |
1 |
|
U-47700 |
2924.29 |
|
1 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
AB-CHMINACA |
2933.99 |
|
2 |
|
AB-PINACA |
2933.99 |
|
2 |
|
Allobarbital (INN) |
2933.53 |
52-43-7 |
4 |
|
Allobarbital aminophenazone |
2933.54 |
4 |
|
|
Alprazolam (INN) |
2933.91 |
28981-97-7 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
AM-2201; JWH-2201 |
2933.99 |
|
2 |
|
Amfepramone (INN) |
2922.31 |
90-84-6 |
4 |
|
Amfepramone glutamate |
2922.42 |
4 |
|
|
Amfepramone hydrochloride |
2922.31 |
134-80-5 |
4 |
|
Amfepramone resinate |
3003.90 |
4 |
|
|
Amfetamine (INN) |
2921.46 |
300-62-9 |
2 |
|
Amfetamine acetylsalicylate |
2921.46 |
2 |
|
|
Amfetamine adipate |
2921.46 |
2 |
|
|
Amfetamine p-aminophenylacetate |
2922.49 |
2 |
|
|
Amfetamine aspartate |
2922.49 |
2 |
|
|
Amfetamine p-chloro- phenoxyacetate |
2921.46 |
2 |
|
|
Amfetamine hydrochloride |
2921.46 |
2 |
|
|
Amfetamine hydrogen tartrate (bitartrate) |
2921.46 |
2 |
|
|
Amfetamine pentobarbiturate |
2933.54 |
2 |
|
|
Amfetamine phosphate |
2921.46 |
139-10-6 |
2 |
|
Amfetamine resinate |
3003.90 |
2 |
|
|
Amfetamine sulfate |
2921.46 |
60-13-9 |
2 |
|
Amfetamine tannate |
3201.90 |
2 |
|
|
Amfetamine tartrate |
2921.46 |
2 |
|
|
Amineptine (INN) |
2922.49 |
2 |
|
|
Amineptine hydrochloride |
2922.49 |
2 |
|
|
Aminorex (INN) |
2934.91 |
2207-50-3 |
4 |
|
Aminorex fumarate |
2934.91 |
|
4 |
|
Aminorex hydrochloride |
2934.91 |
|
4 |
|
Amobarbital (INN) |
2933.53 |
57-43-2 |
3 |
|
Amobarbital resinate |
3003.90 |
3 |
|
|
Amobarbital sodium |
2933.53 |
64-43-7 |
3 |
|
Barbital (INN) |
2933.53 |
57-44-3 |
4 |
|
Barbital calcium |
2933.53 |
4 |
|
|
Barbital magnesium |
2933.53 |
4 |
|
|
Barbital sodium |
2933.53 |
144-02-5 |
4 |
|
Benzfetamine (INN) |
2921.46 |
156-08-1 |
4 |
|
Benzfetamine hydrochloride |
2921.46 |
5411-22-3 |
4 |
|
N-Benzylpiperazine; Benzylpiperazine; BZP |
2933.59 |
|
2 |
|
N-Benzylpiperazine dihydrochloride |
2933.59 |
|
2 |
|
N-Benzylpiperazine hydrochloride |
2933.59 |
|
2 |
|
25B-NBOMe; 2C-B-NBOMe |
2922.29 |
|
1 |
|
25B-NBOMe hydrochloride |
2922.29 |
|
1 |
|
Brolamfetamine (INN) (DOB) |
2922.29 |
64638-07-9 |
1 |
|
Brolamfetamine (DOB) hydrochloride |
2922.29 |
1 |
|
|
Bromazepam (INN) |
2933.33 |
1812-30-2 |
4 |
|
Brotizolam (INN) |
2934.91 |
57801-81-7 |
4 |
|
Buprenorphine (INN) |
2939.11 |
52485-79-7 |
3 |
|
Buprenorphine hydrochloride |
2939.11 |
53152-21-9 |
3 |
|
Buprenorphine hydrogen tartrate (bitartrate) |
2939.11 |
3 |
|
|
Buprenorphine sulfate |
2939.11 |
3 |
|
|
Butalbital (INN) |
2933.53 |
77-26-9 |
3 |
|
Butobarbital |
2933.53 |
77-28-1 |
4 |
|
Camazepam (INN) |
2933.91 |
36104-80-0 |
4 |
|
Cathine (INN) |
2939.43 |
492-39-7 |
3 |
|
Cathine hydrochloride |
2939.43 |
2153-98-2 |
3 |
|
Cathine phenobarbiturate |
2939.43 |
3 |
|
|
Cathine resinate |
3003.49 |
3 |
|
|
Cathine sulfate |
2939.43 |
3 |
|
|
Cathinone (INN) |
2939.79 |
71031-15-7 |
1 |
|
Cathinone hydrochloride |
2939.79 |
1 |
|
|
2C-B |
2922.29 |
2 |
|
|
2C-B hydrochloride |
2922.29 |
2 |
|
|
Chlordiazepoxide (INN) |
2933.91 |
58-25-3 |
4 |
|
Chlordiazepoxide dibunate |
2933.91 |
4 |
|
|
Chlordiazepoxide hydrochloride |
2933.91 |
438-41-5 |
4 |
|
Clobazam (INN) |
2933.72 |
22316-47-8 |
4 |
|
Clonazepam (INN) |
2933.91 |
1622-61-3 |
4 |
|
Clorazepate |
2933.91 |
4 |
|
|
Clorazepate dipotassium |
2933.91 |
57109-90-7 |
4 |
|
Clorazepate monopotassium |
2933.91 |
5991-71-9 |
4 |
|
Clotiazepam (INN) |
2934.91 |
33671-46-4 |
4 |
|
Cloxazolam (INN) |
2934.91 |
24166-13-0 |
4 |
|
Cyclobarbital (INN) |
2933.53 |
52-31-3 |
3 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Cyclobarbital calcium |
2933.53 |
5897-20-1 |
3 |
|
Delorazepam (INN) |
2933.91 |
2894-67-9 |
4 |
|
DET |
2939.79 |
61-51-8 |
1 |
|
DET hydrochloride |
2939.79 |
1 |
|
|
Dexamfetamine (INN) |
2921.46 |
51-64-9 |
2 |
|
Dexamfetamine adipate |
2921.46 |
2 |
|
|
Dexamfetamine carboxy- methylcellulose |
3912.31 |
2 |
|
|
Dexamfetamine hydrochloride |
2921.46 |
405-41-4 |
2 |
|
Dexamfetamine hydrogen tartrate (bitartrate) |
2921.46 |
2 |
|
|
Dexamfetamine pento- barbiturate |
2933.54 |
2 |
|
|
Dexamfetamine phosphate |
2921.46 |
7528-00-9 |
2 |
|
Dexamfetamine resinate |
3003.90 |
2 |
|
|
Dexamfetamine saccharate |
2921.49 |
2 |
|
|
Dexamfetamine sulfate |
2921.46 |
51-63-8 |
2 |
|
Dexamfetamine tannate |
3201.90 |
2 |
|
|
Diazepam (INN) |
2933.91 |
439-14-5 |
4 |
|
DMA |
2922.29 |
1 |
|
|
DMA hydrochloride |
2922.29 |
1 |
|
|
DMHP |
2932.99 |
1 |
|
|
DMT |
2939.79 |
61-50-7 |
1 |
|
DMT hydrochloride |
2939.79 |
1 |
|
|
DMT methyliodide |
2939.79 |
1 |
|
|
DOET |
2922.29 |
1 |
|
|
DOET hydrochloride |
2922.29 |
1 |
|
|
Estazolam (INN) |
2933.91 |
29975-16-4 |
4 |
|
Ethchlorvynol (INN) |
2905.51 |
113-18-8 |
4 |
|
Ethinamate (INN) |
2924.24 |
126-52-3 |
4 |
|
Ethyl loflazepate (INN) |
2933.91 |
29177-84-2 |
4 |
|
N-Ethyl MDA |
2932.99 |
1 |
|
|
N-Ethyl MDA hydrochloride |
2932.99 |
1 |
|
|
Eticyclidine (PCE) (INN) |
2921.49 |
2201-15-2 |
1 |
|
Eticyclidine (PCE) hydrochloride |
2921.49 |
1 |
|
|
Etilamfetamine (INN) |
2921.46 |
457-87-4 |
4 |
|
Etilamfetamine hydrochloride |
2921.46 |
4 |
|
|
Etryptamine (INN) |
2939.79 |
1 |
|
|
Etryptamine acetate |
2939.79 |
1 |
|
|
Etryptamine hydrochloride |
2939.79 |
1 |
|
|
5F-ADB; 5F-MDMB-PINACA |
2933.99 |
2 |
|
|
5F-APINACA; 5F-AKB-48 |
2933.99 |
2 |
|
|
5F-PB-22 |
2933.49 |
2 |
|
|
Fencamfamin (INN) |
2921.46 |
1209-98-9 |
4 |
|
Fencamfamin hydrochloride |
2921.46 |
2240-14-4 |
4 |
|
Fenetylline (INN) |
2939.51 |
3736-08-1 |
2 |
|
Fenetylline hydrochloride |
2939.51 |
1892-80-4 |
2 |
|
Fenproporex (INN) |
2926.30 |
15686-61-0 |
4 |
|
Fenproporex diphenylacetate |
2926.30 |
4 |
|
|
Fenproporex hydrochloride |
2926.30 |
18305-29-8 |
4 |
|
Fenproporex resinate |
3003.90 |
4 |
|
|
Fludiazepam (INN) |
2933.91 |
3900-31-0 |
4 |
|
Flunitrazepam (INN) |
2933.91 |
1622-62-4 |
4 |
|
Flurazepam (INN) |
2933.91 |
17617-23-1 |
4 |
|
Flurazepam dihydrochloride |
2933.91 |
1172-18-5 |
4 |
|
Flurazepam hydrochloride |
2933.91 |
36105-20-1 |
4 |
|
Glutethimide (INN) |
2925.12 |
77-21-4 |
3 |
|
Halazepam (INN) |
2933.91 |
23092-17-3 |
4 |
|
Haloxazolam (INN) |
2934.91 |
59128-97-1 |
4 |
|
N-Hydroxy MDA |
2932.99 |
1 |
|
|
N-Hydroxy MDA hydrochloride |
2932.99 |
1 |
|
|
Ketazolam (INN) |
2934.91 |
27223-35-4 |
4 |
|
Lefetamine (INN) |
2921.46 |
7262-75-1 |
4 |
|
Lefetamine hydrochloride |
2921.46 |
14148-99-3 |
4 |
|
Levamfetamine (INN) |
2921.46 |
156-34-3 |
2 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Levamfetamine alginate |
3913.10 |
2 |
|
|
Levamfetamine succinate |
2921.49 |
5634-40-2 |
2 |
|
Levamfetamine sulfate |
2921.49 |
2 |
|
|
Levometamfetamine |
2939.71 |
2 |
|
|
Levometamfetamine hydrochloride |
2939.71 |
2 |
|
|
Loprazolam (INN) |
2933.55 |
61197-73-7 |
4 |
|
Loprazolam mesilate |
2933.55 |
4 |
|
|
Lorazepam (INN) |
2933.91 |
846-49-1 |
4 |
|
Lorazepam acetate |
2933.91 |
4 |
|
|
Lorazepam mesilate |
2933.91 |
4 |
|
|
Lorazepam pivalate |
2933.91 |
4 |
|
|
Lormetazepam (INN) |
2933.91 |
848-75-9 |
4 |
|
Lysergide (INN), LSD, LSD-25 |
2939.69 |
50-37-3 |
1 |
|
(+)-Lysergide tartrate |
2939.69 |
1 |
|
|
Mazindol (INN) |
2933.91 |
22232-71-9 |
4 |
|
MDMA |
2932.99 |
1 |
|
|
MDMA hydrochloride |
2932.99 |
1 |
|
|
Mecloqualone (INN) |
2933.55 |
340-57-8 |
2 |
|
Mecloqualone hydrochloride |
2933.55 |
2 |
|
|
Medazepam (INN) |
2933.91 |
2898-12-6 |
4 |
|
Medazepam dibunate |
2933.91 |
4 |
|
|
Medazepam hydrochloride |
2933.91 |
4 |
|
|
Mefenorex (INN) |
2921.46 |
17243-57-1 |
4 |
|
Mefenorex hydrochloride |
2921.46 |
4 |
|
|
Meprobamate (INN) |
2924.11 |
57-53-4 |
4 |
|
Mescaline |
2939.79 |
54-04-6 |
1 |
|
Mescaline aurichloride |
2843.30 |
1 |
|
|
Mescaline hydrochloride |
2939.79 |
832-92-8 |
1 |
|
Mescaline picrate |
2939.79 |
1 |
|
|
Mescaline platinichloride |
2843.90 |
1 |
|
|
Mescaline sulfate |
2939.79 |
1152-76-7 |
1 |
|
Mesocarb (INN) |
2934.71 |
34262-84-5 |
4 |
|
Metamfetamine (INN) |
2939.71 |
537-46-2 |
2 |
|
Metamfetamine hydrochloride |
2939.71 |
51-57-0 |
2 |
|
Metamfetamine hydrogen tartrate (bitartrate) |
2939.71 |
2 |
|
|
Metamfetamine racemate |
2939.71 |
4846-07-5 |
2 |
|
Metamfetamine sulfate |
2939.71 |
2 |
|
|
Methaqualone (INN) |
2933.55 |
72-44-6 |
2 |
|
Methaqualone hydrochloride |
2933.55 |
340-56-7 |
2 |
|
Methaqualone resinate |
3003.90 |
2 |
|
|
Methylaminorex |
2934.99 |
1 |
|
|
Methylaminorex hydrochloride |
2934.99 |
1 |
|
|
Methylphenidate (INN) |
2933.33 |
113-45-1 |
2 |
|
Methylphenidate hydrochloride |
2933.33 |
298-59-9 |
2 |
|
Methylphenobarbital (INN) |
2933.53 |
115-38-8 |
4 |
|
Methylphenobarbital sodium |
2933.53 |
4 |
|
|
Methyprylon (INN) |
2933.72 |
125-64-4 |
4 |
|
Midazolam (INN) |
2933.91 |
59467-70-8 |
4 |
|
Midazolam hydrochloride |
2933.91 |
4 |
|
|
Midazolam maleate |
2933.91 |
4 |
|
|
MMDA |
2932.99 |
1 |
|
|
MMDA hydrochloride |
2932.99 |
1 |
|
|
Nimetazepam (INN) |
2933.91 |
2011-67-8 |
4 |
|
Nitrazepam (INN) |
2933.91 |
146-22-5 |
4 |
|
Nordazepam (INN) |
2933.91 |
1088-11-5 |
4 |
|
Oxazepam (INN) |
2933.91 |
604-75-1 |
4 |
|
Oxazepam acetate |
2933.91 |
4 |
|
|
Oxazepam hemisuccinate |
2933.91 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Oxazepam succinate |
2933.91 |
4 |
|
|
Oxazepam valproate |
2933.91 |
4 |
|
|
Oxazolam (INN) |
2934.91 |
24143-17-7 |
4 |
|
Parahexyl |
2932.99 |
1 |
|
|
Pemoline (INN) |
2934.91 |
2152-34-3 |
4 |
|
Pemoline copper |
2934.91 |
4 |
|
|
Pemoline iron |
2934.91 |
4 |
|
|
Pemoline magnesium |
2934.91 |
4 |
|
|
Pemoline nickel |
2934.91 |
4 |
|
|
Pentazocine (INN) |
2933.33 |
359-83-1 |
3 |
|
Pentazocine hydrochloride |
2933.33 |
3 |
|
|
Pentazocine lactate |
2933.33 |
17146-95-1 |
3 |
|
Pentobarbital (INN) |
2933.53 |
76-74-4 |
3 |
|
Pentobarbital calcium |
2933.53 |
7563-42-0 |
3 |
|
Pentobarbital sodium |
2933.53 |
57-33-0 |
3 |
|
Phencyclidine (INN) (PCP) |
2933.33 |
77-10-1 |
2 |
|
Phencyclidine hydrobromide |
2933.33 |
2 |
|
|
Phencyclidine hydrochloride |
2933.33 |
956-90-1 |
2 |
|
Phendimetrazine (INN) |
2934.91 |
634-03-7 |
4 |
|
Phendimetrazine hydrochloride |
2934.91 |
4 |
|
|
Phendimetrazine hydrogen tartrate (bitartrate) |
2934.91 |
50-58-8 |
4 |
|
Phendimetrazine pamoate |
2934.91 |
4 |
|
|
Phenmetrazine (INN) |
2934.91 |
134-49-6 |
2 |
|
Phenmetrazine hydrochloride |
2934.91 |
1707-14-8 |
2 |
|
Phenmetrazine hydrogen tartrate (bitartrate) |
2934.91 |
2 |
|
|
Phenmetrazine sulfate |
2934.91 |
2 |
|
|
Phenmetrazine teoclate |
2939.59 |
13931-75-4 |
2 |
|
Phenobarbital (INN) |
2933.53 |
50-06-6 |
4 |
|
Phenobarbital ammonium |
2933.53 |
4 |
|
|
Phenobarbital calcium |
2933.53 |
58766-25-9 |
4 |
|
Phenobarbital diethylamine |
2933.53 |
4 |
|
|
Phenobarbital diethylaminoethanol |
2933.53 |
4 |
|
|
Phenobarbital lysidine |
2933.53 |
4 |
|
|
Phenobarbital magnesium |
2933.53 |
4 |
|
|
Phenobarbital propylhexedrine |
2933.53 |
4 |
|
|
Phenobarbital quinidine |
2939.20 |
4 |
|
|
Phenobarbital sodium, magnesium |
2933.53 |
4 |
|
|
Phenobarbital sodium (INN) |
2933.53 |
57-30-7 |
4 |
|
Phenobarbital sparteine |
2939.79 |
4 |
|
|
Phenobarbital tetramethyl- ammonium |
2933.53 |
4 |
|
|
Phenobarbital yohimbine |
2939.79 |
4 |
|
|
Phentermine (INN) |
2921.46 |
122-09-8 |
4 |
|
Phentermine hydrochloride |
2921.46 |
1197-21-3 |
4 |
|
Phentermine resinate |
3003.90 |
4 |
|
|
Pinazepam (INN) |
2933.91 |
52463-83-9 |
4 |
|
Pipradrol (INN) |
2933.33 |
467-60-7 |
4 |
|
Pipradrol hydrochloride |
2933.33 |
71-78-3 |
4 |
|
PMA |
2922.29 |
1 |
|
|
PMA hydrochloride |
2922.29 |
1 |
|
|
Prazepam (INN) |
2933.91 |
2955-38-6 |
4 |
|
Psilocine, psilotsin |
2939.79 |
1 |
|
|
Psilocine, psilotsin hydrochloride |
2939.79 |
1 |
|
|
Psilocybine (INN) |
2939.79 |
520-52-5 |
1 |
|
Psilocybine hydrochloride |
2939.79 |
1 |
|
|
Pyrovalerone (INN) |
2933.91 |
3563-49-3 |
4 |
|
Pyrovalerone hydrochloride |
2933.91 |
1147-62-2 |
4 |
II. Psychotropic substances subject to control under the 1971 Convention on Psychotropic Substances (contd.)
|
Name |
HS subheading |
CAS No. |
Convention Schedule No. |
|
Rolicyclidine (INN) (PHP, PCPY) |
2933.99 |
2201-39-0 |
1 |
|
Secbutabarbital (INN) |
2933.53 |
125-40-6 |
4 |
|
Secbutabarbital sodium |
2933.53 |
4 |
|
|
Secobarbital (INN) |
2933.53 |
76-73-3 |
2 |
|
Secobarbital calcium |
2933.53 |
2 |
|
|
Secobarbital resinate |
3003.90 |
2 |
|
|
Secobarbital sodium |
2933.53 |
309-43-3 |
2 |
|
STP, DOM |
2922.29 |
15588-95-1 |
1 |
|
STP, DOM hydrochloride |
2922.29 |
1 |
|
|
Temazepam (INN) |
2933.91 |
846-50-4 |
4 |
|
Tenamfetamine (INN) (MDA) |
2932.99 |
51497-09-7 |
1 |
|
Tenamfetamine (MDA) hydrochloride |
2932.99 |
1 |
|
|
Tenocyclidine (INN) |
2934.99 |
21500-98-1 |
1 |
|
Tenocyclidine hydrochloride |
2934.99 |
1 |
|
|
Tetrahydrocannabinols, all isomers |
2932.95 |
various |
2 |
|
d-9-Tetrahydrocannabinol |
2932.95 |
1972-08-3 |
2 |
|
Tetrazepam (INN) |
2933.91 |
10379-14-3 |
4 |
|
TMA |
2922.29 |
1 |
|
|
TMA hydrochloride |
2922.29 |
1 |
|
|
Triazolam (INN) |
2933.91 |
28911-01-5 |
4 |
|
Vinylbital (INN) |
2933.53 |
2430-49-1 |
4 |
|
Zipeprol (INN) |
2933.55 |
34758-83-3 |
2 |
III. Precursors
|
Name |
HS subheading |
CAS No. |
|
Acetic anhydride |
2915.24 |
108-24-7 |
|
Acetone |
2914.11 |
67-64-1 |
|
N-Acetylanthranilic acid |
2924.23 |
89-52-1 |
|
alpha-Phenylacetoacetonitrile (APAAN) |
2926.40 |
4468-48-8 |
|
Anthranilic acid |
2922.43 |
118-92-3 |
|
Butanone (ethyl methyl ketone) |
2914.12 |
78-93-3 |
|
Diethyl ether |
2909.11 |
60-29-7 |
|
Ephedrine |
2939.41 |
299-42-3 |
|
Ephedrine hydrochloride |
2939.41 |
50-98-6 |
|
Ephedrine nitrate |
2939.41 |
81012-98-8 |
|
Ephedrine sulfate |
2939.41 |
134-72-5 |
|
Ergometrine (INN) |
2939.61 |
60-79-7 |
|
Ergometrine hydrochloride |
2939.61 |
74283-21-9 |
|
Ergometrine hydrogen maleate |
2939.61 |
129-51-1 |
|
Ergometrine oxalate |
2939.61 |
|
|
Ergometrine tartrate |
2939.61 |
129-50-0 |
|
Ergotamine (INN) |
2939.62 |
113-15-5 |
|
Ergotamine hydrochloride |
2939.62 |
|
|
Ergotamine succinate |
2939.62 |
|
|
Ergotamine tartrate |
2939.62 |
379-79-3 |
|
Hydrogen chloride (hydrochloric acid) |
2806.10 |
7647-01-0 |
|
Isosafrole |
2932.91 |
120-58-1 |
|
Lysergic acid |
2939.63 |
82-58-6 |
|
3,4-(Methylenedioxy)phenyl-2- propanone |
2932.92 |
4676-39-5 |
|
Norephedrine |
2939.44 |
14838-15-4 |
|
Norephedrine hydrochloride |
2939.44 |
154-41-6 |
|
Phenylacetone (benzyl methyl ketone, phenylpropan-2-one) |
2914.31 |
103-79-7 |
|
Phenylacetic acid |
2916.34 |
103-82-2 |
|
Piperidine |
2933.32 |
110-89-4 |
|
Piperidine aurichloride |
2843.30 |
|
|
Piperidine hydrochloride |
2933.32 |
6091-44-7 |
|
Piperidine hydrogen tartrate (bitartrate) |
2933.32 |
6091-46-9 |
|
Piperidine nitrate |
2933.32 |
6091-45-8 |
|
Piperidine phosphate |
2933.32 |
|
|
Piperidine picrate |
2933.32 |
6091-49-2 |
|
Piperidine platinichloride |
2843.90 |
|
|
Piperidine thiocyanate |
2933.32 |
22205-64-7 |
|
Piperonal |
2932.93 |
120-57-0 |
|
Potassium permanganate |
2841.61 |
7722-64-7 |
|
Pseudoephedrine (INN) |
2939.42 |
90-82-4 |
|
Pseudoephedrine hydrochloride |
2939.42 |
345-78-8 |
|
Pseudoephedrine sulfate |
2939.42 |
7460-12-0 |
|
Safrole |
2932.94 |
94-59-7 |
|
Sulphuric acid |
2807.00 |
7664-93-9 |
|
Toluene |
2902.30 |
108-88-3 |
______________________
LIST OF PRECURSORS AND ESSENTIAL CHEMICALS WHICH ARE MOST COMMONLY USED IN THE ILLEGAL PRODUCTION OF CERTAIN CONTROLLED SUBSTANCES
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
HEROIN or DIACETY- MORPHINE (2939.11) |
(i) Codeine (P) (2939.11) |
Codicept Coducept 7,8-Didehydro‑4,5- epoxy-3-methoxy-17-methylmorphinan-6-o1 Methylmorphine 3‑O‑Methylmorphine Morphinan‑6‑ol, 7,8‑ didehydro‑4,5‑epoxy‑ 3‑methoxy‑17‑methyl Morphine, 3-methyl ether Morphine monomethyl ether |
76‑57‑3 52‑28‑8 (S) |
|
(ii) Morphine (P) (2939.11) |
7,8‑Didehydro‑4,5‑ epoxy‑17‑methyl‑ morphinan‑3,6‑diol Morphinan‑3,6‑diol, 7,8‑didehydro‑4,5‑ epoxy‑17‑methyl |
57-27-2 (anhydrous) 6009-81-0 (monohydrate) |
|
|
(iii) Acetic anhydride (E) (2915.24) |
Acetanhydride Acetic oxide Acetyl oxide Ethanoic anhydride |
108‑24‑7 |
|
|
(iv) Acetyl chloride (E) (2915.90) |
Ethanoyl chloride |
75‑36‑5 |
|
|
(v) Ethylidene diacetate (E) (2915.39) |
Acetic acid, ethylidene ester 1,1‑Diacetoxyethane |
542‑10‑9 |
|
|
COCAINE or METHYL BENZOYL- ECGONINE (2939.71) |
(i) Acetone (E) (2914.11) |
2‑Propanone Dimethylketone β‑Ketopropane Pyroacetic ether Propane‑2‑one |
67‑64‑1 |
|
(ii) Diethyl ether (E) (2909.11) |
Ethyl ether Ether Ethoxyethane Ethyl oxide Diethyl oxide Anaesthetic ether |
60‑29‑7 |
|
|
(iii) Methyl ethyl ketone (MEK) (E) (2914.12) |
Butanone |
78‑93‑3 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
LYSERGIDE (INN) or LSD or N,N‑DIETHYL- LYSERGAMIDE (2939.69) |
(i) Ergotamine (INN) (P) (2939.62) |
5'‑Benzyl‑12'‑hydroxy‑ 2'‑ methylergotaman-3',6',18‑trione Ergotaman‑3',6',18‑ trione, 12'‑hydroxy‑2'‑ methyl‑5'‑ (phenylmethyl) 12'‑Hydroxy‑2'‑methyl-5'‑(phenylmethyl) ergotaman‑3',6', 18‑ trione Indolo[4,3‑fg]quinoline, ergotaman‑3',6',18‑ trione derivative 8H‑Oxazolo[3,2,‑a]- pyrrolo[2,1‑c]pyrazine, ergotaman‑3',6',18‑ trione derivative N‑(5‑Benzyl‑10b‑ hydroxy‑ 2‑methyl‑3,6-dioxoperhydrooxazolo- [3,2‑a]pyrrolo[2,1‑c]- pyrazin‑2‑yl)‑D‑ lysergamide Ergam Ergate Ergomar Ergostat Ergotamine bitartrate Ergotamine, tartrate (2 : 1) (S) Ergotamini tartras Ergotaman‑3',6',18‑ trione, 12'‑hydroxy‑2'-methyl‑5'‑(phenyl- methyl)‑, ‑2,3dihydroxy-butanedioate (2 : 1) (S) Ergotartrate Etin Exmigra Femergin Gotamine tartrate Gynergene Lingraine Lingran Medihaler Ergotamine Neo‑Ergotine Rigetamine Secagyne Secupan |
113‑15‑5 379‑79‑3 (S) |
|
(ii) Lysergamide (P) (2939.69) |
9,10‑Didehydro‑6‑ methylergoline‑8‑ carboxamide Ergine Ergoline‑8‑carboxamide, 9,10‑didehydro‑6‑methyl Indolo[4,3‑fg]quinoline, ergoline‑8-carboxamide derivative |
478‑94‑4 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
(iii) Lysergic acid (P) (2939.63) |
Ergoline‑8‑carboxylic acid, 9,10‑didehydro‑6‑ methyl- indolo [4,3‑fg] quinoline, ergoline‑8‑carboxylic acid derivative 4,6,6a,7,8,9‑Hexahydro‑ 7‑methylindolo‑[4,3‑fg]- quinoline‑9‑carboxylic acid 9,10‑Didehydro‑ 6‑methyl- ergoline‑8‑ carboxylic acid |
82‑58‑6 |
|
|
(iv) Methyl 6-methylnicotinate (P) (2933.39) |
Methyl 6‑methylpyridine‑3‑ carboxylate 6‑Methylnicotinic acid, methyl ester Nicotinic acid, 6‑methyl‑, methyl ester 3‑Pyridinecarboxylic acid, 6‑methyl‑, methyl ester |
5470‑70‑2 |
|
|
(v) Ergometrine (INN) (P) (2939.61) |
Ergonovine Ergobasine Ergotocine Ergostetrine Ergotrate Ergoklinine Syntometrine 9,10‑Didehydro‑N‑(2‑ hydroxy‑1‑methylethyl)‑ 6‑methylergoline‑8‑ carboxamide N‑(2‑Hydroxy‑1‑methyl‑ etethyl)lysergamide Lysergic acid, 2‑propanolamide |
60‑79‑7 60-79-7 |
|
|
Lysergic acid, 2‑hydroxy‑1‑methylethyl amide Hydroxypropyllyserg‑ amide Basergin Neofemergen Cornocentin Ermetrine |
129‑50‑0 (S) 129‑51‑1 (S) |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
AMFETAMINE (INN) (AMPHETAMINE) or α‑METHYL- PHENETHYLAMINE (2921.46) |
(i) Allylbenzene (P) (2902.90) |
3‑Phenylprop‑1‑ene |
300‑57‑2 |
|
(ii) Phenyl-acetone (P) (2914.31) |
P‑2‑P Phenylpropan‑2‑one 1‑Phenyl‑2‑oxopropane Benzyl methyl ketone BMK |
103-79-7 |
|
|
(iii) Cathine (INN) (P) (2939.43) |
Norpseudoephedrine Adiposetten N 2‑Amino‑1‑hydroxy‑1‑ phenylpropane 2‑Amino‑2‑methyl‑1‑ phenylethanol 2‑Amino‑1‑phenylpropan-1-ol Benzenemethanol, α‑(1‑aminoethyl) E 50 Exponcit Fugoa‑Depot Katine Miniscap M.D. Minusin(e) Norisoephedrine 1‑Phenyl‑2‑aminopropan-1-ol Phenylpropanolamine Pseudonorephedrin(e) Reduform |
37577-07-04 36393‑56‑3 492-39-7 |
|
|
(iv) Phenylacetic acid (P) (2916.34) |
Benzeneacetic acid α‑Toluic acid |
103‑82‑2 |
|
|
(v) Formamide (P) (2924.19) |
Methanamide Carbamaldehyde Formic acid amide |
75‑12‑7 |
|
|
(vi) Benzaldehyde (P) (2912.21) |
Benzoic aldehyde Benzenecarbonal |
100‑52‑7 |
|
|
(vii) Ammonium formate (E) (2915.12) |
― |
540‑69‑2 |
|
|
(viii) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(ix) Hydroxyl- ammonium chloride (E) (2825.10) |
Hydroxylamine hydrochloride Oxammonium hydro‑ chloride |
5470‑11‑1 |
|
|
(x) Trans-β-Methyl-styrene (P) (2902.90) |
1‑Phenylpropene Prop-1-enylbenzene |
873‑66‑5 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
METHYLENE DIOXYAMPHETA- MINE or MDA or α‑METHYL‑3,4‑ METHYLENE- DIOXYPHEN-ETHYLAMINE (2932.99) |
(i) Piperonal (P) (2932.93) |
1,3‑Benzodioxole‑5‑ carbaldehyde Protocatechualdehyde, methylene ether 1,3‑Benzodioxole‑5‑ carboxaldehyde 3,4‑(Methylenedioxy)-benzaldehyde Heliotropin Piperonylaldehyde Dioxymethyleneproto‑ catechuic aldehyde |
120‑57‑0 |
|
(ii) Safrole (P) (2932.94) |
5‑Allyl‑1,3-benzodioxole 1,2‑Methylenedioxy‑ 4‑prop‑2‑enylbenzene 5‑Prop‑2‑enyl‑1,3‑ benzodioxole |
94‑59‑7 |
|
|
(iii) Isosafrole (P) (2932.91) |
5‑Prop‑1‑enyl‑1,3-benzodioxole 1,2‑Methylenedioxy‑4-prop‑1‑enylbenzene |
120‑58‑1 |
|
|
(iv) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(v) 1-(1,3‑Benzo-dioxole‑5‑yl) propan‑2‑ one (P) (2932.92) |
3,4‑Methylenedioxy-phenylacetone 3,4‑Methylenedioxy-phenylpropane-2-one |
4676‑39‑5 |
|
|
(vi) Ammonium formate (E) (2915.12) |
― |
540‑69‑2 |
|
|
(vii) Hydroxyl-ammonium chloride (E) (2825.10) |
Hydroxylamine hydrochloride Oxammonium hydrochloride |
5470‑11‑1 |
|
|
(viii) Formamide (E) (2924.19) |
Methanamide Carbamaldehyde Formic acid amide |
75‑12‑7 |
|
|
METAMFETAMINE (INN) (METHAMPHE-TAMINE) or 2-METHYLAMINO-1- PHENYLPROPANE or DEOXYEPHEDRINE (2939.71) |
(i) Pheny-lacetone (P) (2914.31) |
P‑2‑P Phenylpropan‑2‑one 1‑Phenyl‑2‑oxopropane Benzyl methyl ketone BMK |
103‑79‑7 |
|
(ii) N‑Methyl-formamide (P) (2924.19) |
Methylformamide |
123‑39‑7 |
|
|
(iii) Benzyl chloride(P) (2903.99) |
(Chloromethyl)benzene α‑Chlorotoluene |
100‑44‑7 |
|
|
(iv) Ephedrine (P) (2939.41) |
1‑Phenyl‑1‑hydroxy‑2‑ methylaminopropane 2‑Methylamino‑1-phenyl-propan-1-ol |
299‑42‑3 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
(v) Methylamine (P) (2921.11) |
Aminomethane Monomethylamin(e) Methanamine |
74‑89‑5 |
|
|
(vi) Phenylacetic acid (P) (2916.34) (vii) Benzaldehyde (P) (2912.21) |
Benzeneacetic acid α‑Toluic acid Benzoic aldehyde Benzenecarbonal |
103‑82‑2 100‑52‑7 |
|
|
METHYLENE- DIOXYMETHAM-PHETAMINE or MDMA or α‑METHYL‑3,4-METHYLENE- DIOXYPHENETHYL- (METHYL)AMINE or XTC (Ecstasy) (2932.99) |
(i) Methylamine (E) (2921.11) |
Aminomethane Monomethylamine Methanamine |
74‑89‑5 |
|
(ii) Piperonal (P) (2932.93) |
1,3‑Benzodioxole‑5‑ carbaldehyde Protocatechualdehyde, methylene ether 1,3‑Benzodioxole‑5‑ carboxaldehyde 3,4‑(Methylenedioxy)‑ benzaldehyde Heliotropin Piperonylaldehyde Dioxymethyleneprotoca‑ technic aldehyde |
120‑57‑0 |
|
|
(iii) Safrole (P) (2932.94) |
5‑Allyl‑1,3‑ benzodioxole 1,2‑Methylenedioxy‑4-prop‑2‑enylbenzene 5‑Prop‑2‑enyl‑1,3‑ benzodioxole |
94‑59‑7 |
|
|
(iv) Isosafrole (P) (2932.91) |
5‑Prop‑1‑enyl‑1,3‑ benzodioxole 1,2‑Methylenedioxy‑4-prop‑1‑enylbenzene |
120‑58‑1 |
|
|
(v) Nitroethane (E) (2904.20) |
― |
79‑24‑3 |
|
|
(vi) 1‑(1,3‑Benzo-dioxole‑5‑yl) propan- 2‑one (P) (2932.92) |
3,4‑Methylenedioxy‑ phenylacetone 3,4‑Methylenedioxyphenyl-propane-2-one |
4676‑39‑5 |
|
|
METHAQUALONE (INN) or 2‑METHYL‑3‑O-TOLYL‑4‑(3H)-QUINAZOLINONE (2933.55) |
(i) Anthranilic acid (P) (2922.43) |
o‑Aminobenzoic acid 2‑Aminobenzoic acid |
118‑92‑3 |
|
(ii) o‑Toluidine (P) (2921.43) |
o‑Aminotoluene 2‑Aminotoluene |
95‑53‑4 |
|
|
(iii) o‑Nitro- toluene (P) (2904.20) |
1-Methyl‑2-nitrobenzene 2‑Nitrotoluene |
88‑72‑2 |
|
|
(iv) Acetic anhydride (E) (2915.24) |
Acetanhydride Acetic oxide Acetyl oxide Ethanoic anhydride |
108‑24‑7 |
|
|
(v) 2‑Methyl‑ 1,3-benzoxazole (P) (2934.99) |
― |
95‑21‑6 |
|
|
(vi) 2-Acetamido- benzoic acid (P) (2924.23) |
2‑Acetylaminobenzoic acid o‑Acetylaminobenzoic acid N‑Acetylanthranilic acid |
89‑52‑1 |
|
CONTROLLED SUBSTANCE (SUBHEADING NUMBER) |
PRECURSOR (P) ESSENTIAL CHEMICAL (E) (SUBHEADING NUMBER) |
SYNONYM |
CHEMICAL ABSTRACTS SERVICE (CAS) NUMBER OF (P) OR (E) OR OF THEIR SALTS (S) |
|
MESCALINE or 3,4,5-TRIMETHOXY-PHENETHYLAMINE (2939.79) |
(i) 3,4,5-Trimethoxy-benzalde-hyde (P) (2912.49) (ii) 3,4,5‑ Trimethoxy-benzoic acid (P) (2918.99) |
3,4,5‑Trimethoxyformyl‑ benzene Gallic acid, trimethyl |
86‑81‑7 118‑41‑2 |
|
(iii) 3,4,5‑Trimeth-oxybenzoyl chloride (P) (2918.99) |
― |
4521‑61‑3 |
|
|
(iv) 3,4,5‑Trimeth-oxybenzyl alcohol (P) (2909.49) |
― |
3840‑31‑1 |
|
|
(v) Nitromethane (E) (2904.20) |
― |
75‑52‑5 |
|
|
PHENCYCLIDINE (INN) or PCP or 1‑(1‑PHENYLCYCLOHEXYL) PIPERIDINE (2933.33) |
(i) Piperidine (P) (2933.32) |
Hexahydropyridine Pentamethylenimine |
110‑89‑4 |
|
(ii) Cyclohexanone (P) (2914.22) |
Pimelic ketone Ketohexamethylene Hytrol o Anone Nadone |
108‑94‑1 |
|
|
(iii) Bromobenzene (P) (2903.99) |
Monobromobenzene Phenyl bromide |
108‑86‑1 |
______________________
CHEMICAL STRUCTURES OF CERTAIN PRODUCTS DESCRIBED IN THE EXPLANATORY NOTES TO CHAPTER 29
|
Page |
Heading |
Paragraph
|
Description in the Explanatory Notes |
Chemical Structure |
||||
|
General |
(G) |
Classification of esters, salts, co-ordination compounds and certain halides |
||||||
|
(1) |
Esters |
|||||||
|
VI-29-7 |
(a) |
|
||||||
|
(b) |
|
|||||||
|
(c) |
(Butyl hydrogenphthalate) 29.17 |
|||||||
|
(VI-29-7) |
(G) |
(1) |
(d) |
|
||||
|
(d) |
|
|||||||
|
(2) |
Salts |
|||||||
|
(a)(i) |
|
|||||||
|
(VI-29-7) |
(G) |
(2) |
(a)(i) |
|
||||
|
VI-29-8 |
(ii) |
|
||||||
|
(b)(i) |
|
|||||||
|
(ii) |
|
|||||||
|
VI-29-9 |
(G) |
(4) |
Halides of carboxylic acids (Isobutyryl chloride : 29.15) |
|
||||
|
29.02 |
Cyclic hydrocarbons |
|||||||
|
(B) |
CYCLOTERPENES |
|||||||
|
VI-2902-2 |
(3) |
Limonene |
|
|||||
|
(C) |
AROMATIC HYDROCARBONS |
|||||||
|
VI-2902-3 |
(I) |
(c) |
o-xylene |
|
||||
|
(d)(1) |
Styrene |
|
||||||
|
(VI-2902-3) |
(29.02) |
(C) |
(I) |
(d)(4) |
p-Cymene |
|
||
|
29.03 |
Halogenated derivatives of hydrocarbons |
|||||||
|
(F) |
HALOGANATED DERIVATIVES OF AROMATIC HYDROCARBONS |
|||||||
|
VI-2903-4 |
(6) |
DDT (ISO) (clofenotane (INN), 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane or dichlorodiphenyltrichloroethane) |
|
|||||
|
(11) |
2.2'.4.4'.5.5'-hexabromobiphenyl |
|
||||||
|
29.04 |
Sulphonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated |
|||||||
|
(A) |
SULPHONATED DERIVATIVES |
|||||||
|
VI-2904-1 |
(1) |
(a) |
Ethylenesulphonic acid |
|
||||
|
(B) |
NITRATED DERIVATIVES |
|||||||
|
(1) |
(d) |
Trinitromethane |
CH(NO2)3 |
|||||
|
(C) |
NITROSATED DERIVATIVES |
|||||||
|
VI-2904-2 |
(2) |
Nitrosotoluene |
|
|||||
|
(D) |
SULPHOHALOGENATED DERIVATIVES |
|||||||
|
(1) |
Chlorobenzenesulphonic acid |
|
||||||
|
(5) |
Perfluorooctane sulphonic acid (PFOS) |
|
||||||
|
3 |
29.05 |
Acyclic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives |
||||||
|
(B) |
UNSATURATED MONOHYDRIC ALCOHOLS |
|||||||
|
VI-2905-3 |
(1) |
Allyl alcohol |
|
|||||
|
(C) |
DIOLS AND OTHER POLYHYDRIC ALCOHOLS |
|||||||
|
(II) |
(4) |
Mannitol |
|
|||||
|
29.06 |
Cyclic alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
CYCLANIC, CYCLENIC OR CYCLOTERPENIC ALCOHOLS AND THEIR HALOGENATED, SULPHONATED, NITRATED OR NITROSATED DERIVATIVES |
|||||||
|
VI-2906-1 |
(1) |
Menthol |
|
|||||
|
29.07 |
Phenols; phenol‑alcohols |
|||||||
|
(A) |
MONONUCLEAR MONOPHENOLS |
|||||||
|
VI-2907-2 |
(2) |
Cresol(s) |
(o-Cresol) (m-Cresol) (p-Cresol) |
|||||
|
(B) |
POLYNUCLEAR MONOPHENOLS |
|||||||
|
(1) |
Naphthol(s) |
(α-Naphthol) (β-Naphthol) |
||||||
|
(C) |
POLYPHENOLS |
|||||||
|
(1) |
Resorcinol |
|
||||||
|
VI-2907-3 |
(29.07) |
(C) |
(3) |
Bisphenol A |
|
|||
|
29.09 |
Ethers, ether‑alcohols, ether‑phenols, ether-alcohol-phenols, alcohol peroxides, ether peroxides, ketone peroxides (whether or not chemically defined), and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(C) |
ETHER-PHENOLS AND ETHER-ALCOHOL-PHENOLS |
|||||||
|
VI-2909-3 |
(1) |
Guaiacol |
|
|||||
|
(D) |
ALCOHOL PEROXIDES, ETHER PEROXIDES AND KETONE PEROXIDES |
|||||||
|
VI-2909-4 |
Ketone peroxides (Cyclohexanone peroxide) |
|
||||||
|
29.10 |
Epoxides, epoxyalcohols, epoxyphenols and epoxyethers, with a three-membered ring, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2910-1 |
(1) |
Oxirane |
|
|||||
|
29.11 |
Acetals and hemiacetals, whether or not with other oxygen function, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2911-1 |
(A) |
ACETALS AND HEMIACETALS |
|
|||||
|
Peroxyketals 1,1-di(tert-butylperoxy)cyclohexane |
|
|||||||
|
29.12 |
Aldehydes, whether or not with other oxygen function; cyclic polymers of aldehydes; paraformaldehyde |
|||||||
|
VI-2912-2 |
(A) |
ALDEHYDES |
|
|||||
|
VI-2912-3 |
(IV) |
(1) |
Benzaldehyde |
|
||||
|
(B) |
ALDEHYDE-ETHERS, ALDEHYDE-PHENOLS AND ALDEHYDES WITH OTHER OXYGEN FUNCTION |
|||||||
|
(4) |
Vanillin |
|
||||||
|
(C) |
CYCLIC POLYMERS OF ALDEHYDES |
|||||||
|
VI-2912-4 |
(1) |
Trioxan |
|
|||||
|
29.14 |
Ketones and quinones, whether or not with other oxygen function, and their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2914-2 |
(A) |
(I) |
KETONES |
|
||||
|
(8) |
Diacetyl |
|
||||||
|
(9) |
Acetylacetone |
|
||||||
|
(10) |
Acetonylacetone |
|
||||||
|
(II) |
(1) |
Camphor |
|
|||||
|
VI-2914-4 |
(29.14) |
(E) |
QUINONES |
|||||
|
(1) |
Anthraquinone |
|
||||||
|
|
(29.14) |
(F) |
|
|
QUINONE-ALCOHOLS, QUINONE-PHENOLS, QUINONE-ALDEHYDES AND OTHER OXYGEN FUNCTION QUINONES |
|||
|
(4) |
Coenzyme Q10 (ubidecarenone (INN)) |
|
||||||
|
29.15 |
Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
VI-2915-1 |
(C) |
ACID PEROXIDES |
|
|||||
|
VI-2915-5 |
(V) |
(a) |
n-Butyric acid |
|
||||
|
29.16 |
Unsaturated acyclic monocarboxylic acids, cyclic monocarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
UNSATURATED ACYCLIC MONOCARBOXYLIC ACIDS AND THEIR SALTS, ESTERS AND OTHER DERIVATIVES |
|||||||
|
VI-2916-1 |
(1) |
Acrylic acid |
|
|||||
|
(C) |
AROMATIC SATURATED MONOCARBOXYLIC ACIDS AND THEIR SALTS, ESTERS AND OTHER DERIVATIVES |
|||||||
|
VI-2916-2 |
(1) |
Benzoic acid |
|
|||||
|
(a) |
Benzoyl peroxide |
|
||||||
|
(VI-2916-2) |
(29.16) |
(C) |
(1) |
(b) |
Benzoyl chloride |
|
||
|
29.17 |
Polycarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
ACYCLIC POLYCARBOXYLIC ACIDS AND THEIR ESTERS, SALTS AND DERIVATIVES |
|||||||
|
VI-2917-1 |
(3) |
Azelaic acid |
|
|||||
|
VI-2917-2 |
(5) |
Maleic anhydride |
|
|||||
|
(C) |
AROMATIC POLYCARBOXYLIC ACIDS AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
(1) |
Phthalic anhydride |
|
||||||
|
(VI-2917-2) |
(29.17) |
(C) |
(2) |
Terephthalic acid |
|
|||
|
29.18 |
Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
CARBOXYLIC ACIDS WITH ALCOHOL FUNCTION AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
VI-2918-2 |
(3) |
Citric acid |
|
|||||
|
VI-2918-3 |
(29.18) |
(A) |
(6) |
Phenylglycolic acid |
|
|||
|
(8) |
2,2-Diphenyl-2-hydroxyacetic acid (benzilic acid) |
|
||||||
|
(B) |
CARBOXYLIC ACIDS WITH PHENOL FUNCTION AND THEIR ESTERS, SALTS AND OTHER DERIVATIVES |
|||||||
|
(VI-2918-3) |
(29.18) |
(B) |
(I) |
Salicylic acid |
|
|||
|
29.19 |
Phosphoric esters and their salts, including lactophosphates; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|
|||||
|
VI-2919-2 |
(3) |
Tributyl phosphate |
|
|||||
|
29.20 |
Esters of other inorganic acids of non-metals (excluding esters of hydrogen halides) and their salts; their halogenated, sulphonated, nitrated or nitrosated derivatives |
|||||||
|
(A) |
Thiophosphoric esters |
|||||||
|
VI-2920-1 |
Sodium O,O-dibutyldithiophosphates |
|
||||||
|
|
(B) |
|
|
PHOSPHITE ESTERS AND THEIR SALTS. |
|
|||
|
Dimethyl phosphite |
|
|||||||
|
VI-2920-2 |
(D) |
Nitrous and nitric esters |
||||||
|
Methyl nitrite |
|
|||||||
|
(VI-2920-2) |
(29.20) |
(D) |
Nitroglycerol |
|
||||
|
(E) |
Carbonic or peroxocarbonic esters and their salts |
|||||||
|
(1) |
Diguaiacyl carbonate |
|
||||||
|
(F) |
Silicic acid esters and their salts |
|||||||
|
Tetraethyl silicate |
|
|||||||
|
VI-2921-1 |
29.21 |
Amine-function compounds |
|
|||||
|
(A) |
ACYCLIC MONOAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
VI-2921-2 |
(4) |
Ethylamine |
CH3-CH2-NH2 |
|||||
|
(VI-2921-2) |
(29.21) |
(B) |
ACYCLIC POLYAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
VI-2921-3 |
(2) |
Hexamethylenediamine |
|
|||||
|
(D) |
AROMATIC MONOAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
(1) |
Aniline |
|
||||||
|
(2) |
Toluidine(s) |
|
||||||
|
(4) |
1-Naphtylamine |
|
||||||
|
(VI-2921-4) |
(29.21) |
(E) |
AROMATIC POLYAMINES AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
(1) |
Phenylenediamine(s) |
|
||||||
|
29.22 |
Oxygen-function amino-compounds |
|||||||
|
(A) |
AMINO-ALCOHOLS, THEIR ETHERS AND ESTERS; SALTS THEREOF |
|||||||
|
VI-2922-2 |
(1) |
Monoethanolamine |
|
|||||
|
(B) |
AMINO-NAPHTHOLS AND OTHER AMINO-PHENOLS, THEIR ETHERS AND ESTERS; SALTS THEREOF |
|||||||
|
(1) |
Aminohydroxynaphthalenesulphonic acids |
|
||||||
|
VI-2922-3 |
(29.22) |
(B) |
(a) |
Anisidine(s) |
|
|||
|
(b) |
Dianisidine(s) |
|
||||||
|
(D) |
AMINO-ACIDS AND THEIR ESTERS; SALTS THEREOF |
|||||||
|
(1) |
Lysine |
|
||||||
|
29.23 |
Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined |
|||||||
|
VI-2923-1 |
(1) |
Choline (Choline hydroxide) |
|
|||||
|
(VI-2923-1) |
(29.23) |
(2) |
Lecithin |
|
||||
|
29.24 |
Carboxyamide-function compounds; amide-function compounds of carbonic acid |
|||||||
|
(B) |
CYCLIC AMIDES |
|||||||
|
VI-2924-2 |
(1) |
(ii) |
Diethyldiphenylurea |
|
||||
|
29.25 |
Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds |
|||||||
|
(A) |
IMIDES |
|||||||
|
VI-2925-1 |
(1) |
Saccharin |
|
|||||
|
(VI-2925-1) |
(29.25) |
(B) |
IMINES |
|||||
|
(1) |
guanidine |
 |
||||||
|
VI-2925-2 |
(a) |
Diphenylguanidine |
|
|||||
|
(3) |
Imino ethers |
|
||||||
|
29.26 |
Nitrile-function compounds |
|||||||
|
VI-2926-1 |
(1) |
Acrylonitrile |
|
|||||
|
(2) |
1-Cyanoguanidine |
|
||||||
|
(VI-2926-1) |
(29.26) |
(19) |
alpha-Phenylacetoacetonitrile (APAAN) |
|
||||
|
29.27 |
Diazo-, azo- or azoxy-compounds |
|||||||
|
(A) |
DIAZO-COMPOUNDS |
|||||||
|
VI-2927-1 |
(1) |
(a) |
Benzenediazonium chloride |
|
||||
|
(B) |
AZO-COMPOUNDS |
R1N = NR2 |
||||||
|
VI-2927-2 |
(C) |
AZOXY-COMPOUNDS |
R1-N2O-R2 |
|||||
|
(1) |
Azoxybenzene |
|
||||||
|
29.28 |
Organic derivatives of hydrazine or of hydroxylamine |
|||||||
|
VI-2928-1 |
(1) |
Phenylhydrazine |
|
|||||
|
(11) |
Phenylglyoxime |
|
||||||
|
29.29 |
Compounds with other nitrogen function |
|||||||
|
VI-2929-1 |
(1) |
Isocyanates |
|
|||||
|
S-Ch. X General |
ORGANO-INORGANIC COMPOUNDS, HETEROCYCLIC COMPOUNDS, NUCLEIC ACIDS AND THEIR SALTS, AND SULPHONAMIDES |
|||||||
|
(A) |
FIVE-MEMBERED RINGS |
|||||||
|
VI-2930-1 |
(1) |
(a) |
Furan |
|
||||
|
(VI-2930-1) |
(General) |
(A) |
(1) |
(b) |
Thiophen |
|
||
|
(c) |
Pyrrole |
|
||||||
|
(2) |
(a) |
Oxazole |
|
|||||
|
(a) |
Isoxazole |
|
||||||
|
(b) |
Thiazole |
|
||||||
|
(VI-2930-1) |
(General) |
(A) |
(2) |
(c) |
Imidazole |
|
||
|
(c) |
Pyrazole |
|
||||||
|
(3) |
(a) |
Furazan |
|
|||||
|
(b) |
Triazole (1,2,4-Triazole) |
|
||||||
|
(c) |
Tetrazole |
|
||||||
|
VI-2930-2 |
(General) |
(B) |
SIX-MEMBERED RINGS |
|||||
|
(1) |
(a) |
Pyran (2H-Pyran) |
|
|||||
|
(b) |
Thiin |
|
||||||
|
(c) |
Pyridine |
|
||||||
|
(2) |
(a) |
Oxazine (1,4-Oxazine) |
|
|||||
|
(b) |
Thiazine (1,4-Thiazine) |
|
||||||
|
(VI-2930-2) |
(General) |
(B) |
(2) |
(c) |
Pyridazine |
|
||
|
(c) |
Pyrimidine |
|
||||||
|
(c) |
Pyrazine |
|
||||||
|
(c) |
Piperazine |
|
||||||
|
(C) |
OTHER MORE COMPLEX HETEROCYCLIC COMPOUNDS |
|||||||
|
(a) |
Coumarone |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(b) |
Benzopyran |
|
|||
|
(c) |
Xanthene |
|
||||||
|
(d) |
Indole |
|
||||||
|
(e) |
Quinoline and isoquinoline |
|
||||||
|
(f) |
Acridine |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(g) |
Benzothiophene (Thionaphthene) |
|
|||
|
(h) |
Indazole |
|
||||||
|
(ij) |
Benzimidazole |
|
||||||
|
(k) |
Phenazine |
|
||||||
|
(l) |
Phenoxazine |
|
||||||
|
(VI-2930-2) |
(General) |
(C) |
(m) |
Benzoxazole |
|
|||
|
(n) |
Carbazole |
|
||||||
|
(o) |
Quinazoline |
|
||||||
|
(p) |
Benzothiazole |
|
||||||
|
29.30 |
Organo-sulphur compounds |
Compounds with C-S bond |
||||||
|
VI-2930-3 |
(A) |
DITHIOCARBONATES (XANTHATES) |
ROC(S)SR1 R1 = Metal or an organic radical |
|||||
|
(1) |
Sodium ethyldithiocarbonate |
|
||||||
|
(VI-2930-3) |
(29.30) |
(B) |
THIOCARBAMATES, DITHIOCARBAMATES AND THIURAM SULPHIDES |
|||||
|
(2) |
Dithiocarbamates |
|
||||||
|
VI-2930-4 |
(C) |
SULPHIDES (OR THIOETHERS) |
|
|||||
|
(1) |
Methionine |
|
||||||
|
(D) |
THIOAMIDES |
|
||||||
|
(2) |
Thiocarbanilide |
|
||||||
|
29.31 |
Other organo-inorganic compounds |
|||||||
|
|
(3) |
|
|
Organo-phosphorus compounds |
Compounds with C-P bond |
|||
|
Dimethyl methylphosphonate |
|
|||||||
|
(VI-2931-1) |
(29.31) |
(4) |
Organo-silicon compounds |
Compounds with C-Si bond |
||||
|
Hexamethyldisiloxane |
|
|||||||
|
29.32 |
Heterocyclic compounds with oxygen hetero-atom(s) only |
|||||||
|
VI-2932-1 |
(A) |
Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure |
(See structure of furan against page VI-2930-1 for Sub-Chapter X (A) (1) (a)) |
|||||
|
(2) |
2-Furaldehyde |
|
||||||
|
(3) |
Furfuryl alcohol |
|
||||||
|
(5) |
Sucralose |
|
||||||
|
VI-2932-2 |
(29.32) |
(B) |
Lactones |
|
||||
|
(a) |
Coumarin |
|
||||||
|
VI-2932-3 |
(p) |
Phenolphthalein |
|
|||||
|
(C) |
Other heterocyclic compounds with oxygen hetero-atom(s) only |
|||||||
|
(5) |
Safrole |
|
||||||
|
(VI-2932-3) |
(29.32) |
(C) |
(8) |
Piperonal |
|
|||
|
VI-2932-4 |
(10) |
1-(1,3-Benzodioxol-5-yl)propan-2-one |
|
|||||
|
Ketone peroxides (exclusion) – see 29.09 |
|
|||||||
|
Example for esters (lactone) forming part of two rings (Subheading Explanatory Notes) |
|
|||||||
|
Example for dilactone (Subheading Explanatory Notes) |
|
|||||||
|
(VI-2932-4) |
(29.32) |
Internal Hemiacetals |
|
|||||
|
29.33 |
Heterocyclic compounds with nitrogen hetero-atom(s) only |
|||||||
|
VI-2933-2 |
(A) |
Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure |
(See structure of pyrazole against page VI-2930-1 for Sub-Chapter X (A) (2) (c)) |
|||||
|
(1) |
Phenazone |
|
||||||
|
(VI-2933-2) |
(29.33) |
(B) |
Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure |
(See structure of imidazole against page VI-2930-1 for Sub-Chapter X (A) (2) (c)) |
||||
|
(1) |
Hydantoin |
|
||||||
|
VI-2933-3 |
(C) |
Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure |
(See structure of pyridine against page VI-2930-2 for Sub-Chapter X (B) (1) (c)) |
|||||
|
VI-2933-4 |
(D) |
Compounds containing a quinoline or isoquiniline ring-system (whether or not hydrogenated), not further fused |
(See structures of quinoline and isoquinoline against page VI-2930-2 for Sub-Chapter X (C) (e)) |
|||||
|
(4) |
Tetrahydromethylquinoline (5,6,7,8-Tetrahydromethylquinoline) |
|
||||||
|
(E) |
Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure |
(See structure of pyrimidine against page VI-2930-2 for Sub-Chapter X (B) (2) (c)) |
||||||
|
(1) |
Malonylurea (Barbituric acid) |
|
||||||
|
VI-2933-5 |
(29.33) |
(F) |
Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure |
|
||||
|
(1) |
Melamine |
|
||||||
|
(G) |
Lactams |
|
||||||
|
VI-2933-6 |
(29.33) |
(H) |
Other heterocyclic compounds with nitrogen hetero-atom(s) only |
|||||
|
(1) |
Carbazole |
|
||||||
|
(2) |
Acridine |
(See structure of acridine against page VI-2930-2 for Sub-Chapter X (C) (f)) |
||||||
|
VI-2933-7 |
Oxazepam (Subheading Explanatory Notes) |
|
||||||
|
Example for amide (lactam) forming part of two rings (Subheading Explanatory Notes) |
|
|||||||
|
29.34 |
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds |
|||||||
|
VI-2934-1 |
(A) |
Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure |
(See structure of thiazole against page VI-2930-1 for Sub-Chapter X (A) (2) (b)) |
|||||
|
(B) |
Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fused |
(See structure of benzothiazole against page VI-2930-2 for Sub-Chapter X (C) (p)) |
||||||
|
VI-2934-2 |
(C) |
Compounds containing a phenothiazine ring-system (whether or not hydrogenated), not further fused |
|
|||||
|
(D) |
Other heterocyclic compounds |
|||||||
|
(1) |
Sultones |
|
||||||
|
(a) |
Phenolsulfonephthalein |
|
||||||
|
(VI-2934-2) |
(29.34) |
(D) |
(2) |
Sultams |
|
|||
|
(4) |
Furazolidone (INN) |
|
||||||
|
VI-2935-1 |
29.35 |
Sulphonamides |
|
|||||
|
(1) |
Perfluorooctane sulphonamide |
|
||||||
|
(5) |
p-Aminobenzenesulphonamide |
|
||||||
|
29.37 |
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones |
|||||||
|
(V) |
Analogues of hormones, prostaglandins, thromboxanes and leukotrienes |
|||||||
|
VI-2937-2 |
(b) |
Gonane |
|
|||||
|
(B) |
STEROIDAL HORMONES, THEIR DERIVATIVES AND STRUCTURAL ANALOGUES |
|||||||
|
(1) |
Corticosteroid hormones |
|||||||
|
VI-2937-5 |
(a) |
Cortisone (INN) |
|
|||||
|
(VI-2937-5) |
(29.37) |
(B) |
(1) |
(b) |
Hydrocortisone (INN) |
|
||
|
VI-2937-6 |
(3) |
Oestrogens and progestogens |
||||||
|
(a) |
Progesterone (INN) |
|
||||||
|
VI-2937-8 |
List |
Androstane |
|
|||||
|
VI-2937-9 |
(29.37) |
List |
Estrone (INN) |
|
||||
|
VI-2937-12 |
Prednisolone (INN) |
|
||||||
|
Prednisone (INN) |
|
|||||||
|
VI-2937-13 |
(29.37) |
List |
Testosterone (INN) |
|
||||
|
- |
Estrane |
|
||||||
|
- |
Pregnane |
|
||||||
|
29.38 |
Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives |
|||||||
|
VI-2938-1 |
(1) |
Rutoside |
|
|||||
|
29.39 |
Vegetable alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives |
|||||||
|
(A) |
ALKALOIDS OF OPIUM AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
VI-2939-2 |
(1) |
Morphine |
|
|||||
|
(VI-2939-3) |
(29.39) |
(B) |
ALKALOIDS OF CINCHONA AND THEIR DERIVATIVES; SALTS THEREOF |
|||||
|
(1) |
Quinine |
|
||||||
|
(C) |
CAFFEINE AND ITS SALTS |
|||||||
|
Caffeine |
|
|||||||
|
(VI-2939-3) |
(29.39) |
(D) |
EPHEDRINES AND THEIR SALTS |
|||||
|
(1) |
Ephedrine |
|
||||||
|
(E) |
THEOPHYLLINE AND AMINOPHYLLINE (THEOPHYLLINE-ETHYLENEDIAMINE) AND THEIR DERIVATIVES; SALTS THEREOF |
|||||||
|
(E) |
Theophylline |
|
||||||
|
(VI-2939-3) |
(29.39) |
(G) |
NICOTINE AND ITS SALTS |
|||||
|
Nicotine |
|
|||||||
|
VI-2939-6 |
|
|
OTHER ALKALOIDS OF NON VEGETAL ORIGIN |
|||||
|
(IJ) |
Viridicatin (fungal), histrionicotoxin (animal), coccinelline (insect), varacin (marine) and procyanine (bacterial) |
|
||||||
|
29.40 |
Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 29.37, 29.38 or 29.39 |
|||||||
|
(A) |
SUGARS, CHEMICALLY PURE |
|||||||
|
(1) |
Galactose |
|
||||||
|
(B) |
SUGAR ETHERS, SUGAR ACETALS AND SUGAR ESTERS, AND THEIR SALTS |
|||||||
|
VI-2940-2 |
(1) |
Hydroxypropyl sucrose |
|
|||||
|
29.41 |
Antibiotics |
|||||||
|
VI-2941-1 |
(1) |
Penicillins |
|
|||||
|
(VI-2941-1) |
(29.41) |
(2) |
Streptomycin |
|
||||
|
VI-2941-2 |
Streptamine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
||||||
|
(VI-2941-2) |
(29.41) |
Streptidine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||
|
Methylglucosamine (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
|
|||||||
|
5-deoxylyxose (constituent of the streptomycin skeleton) (Subheading Explanatory Notes) |
 |
|||||||
|
VI-2941-1 |
(3) |
Tetracycline |
|
|||||
|
VI-2941-3 |
(29.41) |
(3) |
4-dimethylamino-naphthacene-2-carboxamide (fully hydrogenated) (constituent of the tetracycline skeleton) (Subheading Explanatory Notes) |
|
||||
|
(4) |
N-(2-hydroxy-1-methyl-2-phenethyl)acetamide (constituent of the chloramphenicol skeleton) (Subheading Explanatory Notes) |
|
||||||
|
VI-2941-1 |
(5) |
Erythromycin |
|
|||||
|
(VI-2941-3) |
(29.41) |
(5) |
13-ethyl-13-tridecanolide (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
|
||||
|
Desosamine (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
 |
|||||||
|
Mycarose (constituent of the erythromycin skeleton) (Subheading Explanatory Notes) |
 |
|||||||
|
29.42 |
Other organic compounds |
|||||||
|
VI-2942-1 |
(1) |
Ketenes |
|
|||||
|
(2) |
Boron trifluoride complexes with diethyl ether |
|
||||||
______________________
(*) Dextromethorphan (INN) ((+)-3- methoxy-N- Methylmorphinan) is specifically excluded from thislist.
(**) Dextrophane (INN) ((+)-3-hydroxy-N-methylmorphinan) is specifically excluded from this list.
(*) Other substances not added.
(**) Natural mixtures, constituents other than alkaloids sufficiently removed, other substances not added .
WCO Trade Tools ofrece información esencial para apoyar su actividad comercial.
